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The Mammogenic Hormones of 
the Anterior Pituitary. 
II. The Lobule-Alveolar Growth 
Factor 
JOHN P. MIXNER AND C. W. TURNER 
During the past decade and a half endocrine research has come to center around the anterior hypophysis as the master gland in hormonal regulation and interrelation, especially in relation to 
reproduction and associated phenomena. Of the many body pro-
cesses with which the anterior pituitary has been associat ed, those 
of mammary gland growth and secretion have received their due 
share of attention. 
The investigations to be reported in this paper are the contin-
uation of studies resulting in the discovery of a factor in the anterior pituitary, named "mammogen," which directly stimulates t he growth 
of the mammary gland parenchyma. It is m;>t an over statement to say that it is now generally acknowledged that there is a pituitary factor which is vitally concerned in the direct stimulation of mam-
mary growth. The details of this control are, however, a matter of 
considerable debate at the present time. 
The present studies are concerned primarily with the anterior pituitary factor which directly stimulates mammary lobule-alveo-lar growth, and with other factors which indirectly affect alveolar growth. It was necessary to develop an assay technic for this an-terior pituitary mammogenic lobule-alveolar growth factor to be 
used as a tool in these investigations. 
The points that were given particular study include the following: 1. The determination of the rble of estrogen in the stimu-lation of mammary growth. 
2. The demonstration of the relationship of the mammo-genic lobule-alveolar growth factor to other anter-ior pituitary hormones. 
3. The determination of the relat ive ability of progesterone 
and certain progesterone-like materials to stimulate lob-
ule-alveolar growth. 
4. T.he influence of certain adverse conditions on the growth 
of the mammary lobule-alveolar system. 
5. The . effects of thyroxine and thyroidectomy upon mam-
mary lobule-alveolar growth. 
. 
6. Investigation of the relative effects of progesterone and diethylstilbestrol upon the mammary glands of virgin female goats. 
It cannot be claimed that complete answers have been found to the above problems, but at least a background of research has been developed which· can be used as the basis for fut ure research on these and related :i:>roblems. 
· 
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GENERAL REVIEW OF LITERATURE 
A. Normal Development of the Mammary Gland 
The literature on the normal growth of the mammary gland has been extensively reviewed by Turner (1939). Briefly the develop-
ment of the mammary glands of the female from birth to post-parturient lactation may be divided into the following periods: (I) birth to puberty; (2) puberty; (3) pregnancy; and (4) lacta-
tion. 
At birth the mammary glands of the typical mammal consists of 
the primary duct from which secondary ducts have sprouted. From birth to puberty very little mammary growth occurs, although there 
may be a slight extension of the secondary ducts. During puberty 
with recurring estrous cycles considerable development of the 
mammary duct tree takes place. In certain species such as the dog in which a long luteal phase follows ovulation, mammary gland development similar to that which occurs during pregnancy 
takes place. Complete growth of the mammary lobule-alveolar 
system takes place during the first half to two-thirds of pregnancy. During the last third of pregnancy there is considerable swelling 
of the gland with secretion, but this is not accompanied by much 
actual proliferation of glandular tissue. Considerable confusion in· the literature on mammary growth has arisen because of a -lack 
of appreciation of this fact. Increase in the size of the gland due to the onset of secretion has been mistakenly called growth. Investigations also indicate that in the absence of pregnancy there is very little, if any, new growth during lactation, only a main-
tenance of existing structures. 
This paper is concerned with the factors which are responsible for the growth of the mammary gland during the first two-thirds 
of pregnancy. Such growth will be spoken of as mammary lobule-
alveolar growth. This is in contrast to mammary duct growth 
which occurs primarily during the estrous cycles of puberty. 
B. Experimental Development of the Mammary Gland with Anter-
ior Pituitary Materials 
1. Positive Results.-The early exper.iments on the growth of 
the mammary gland with pituitary materials are complicated by 
the fact that lactation was usually simultaneously initiated. It is very difficult to observe whether growth has been .stimulated 
when lactation is also initiated. It is doubtful in most of these 
early experiments if true hyperplasia of the gland was caused 
rather than a hypertrophy due to secretion, especially since lac-
togenic extracts were usually employed. 
The pioneer experiment on the growth of the mammary gland 
with pituitary materials was reported by Corner (1930). * Young se~ually mature castrate rabbits were injected for fourteen days 
*For list of references, see page 56. 
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with an alkaline extract of sheep anterior pituitary. He stated that a growth of the mammary gland was secured. which was scarcely distinguishable from that seen at full pregnancy. Nelson and Pfiffner (1931) similarly claimed that t hey secured full mammary development in castrate rats given an extract of the anterior pituitary plus an extract of the corpus luteum, the 
corpus luteum extract being ineffective alone. 
Asdell (1931) also reported that spayed virgin female rabbits were brought into full mammary development with alkaline extracts 
of the anterior pituitary. 
Using the ovariectomized mouse as an experimental animal, Brad-bury (1932) reported that he secured alveolar development of their 
mammary glands with pituitary extracts. 
Catchpole and Lyons (1933) also reported securing extensive duct and alveolar development in spayed female rabbits given daily injections of anterior pituitary extracts. 
Later, Lyons (1936) claimed that he secured alveolar proliferation 
of mammary glands of a male rabbit pretreated with estrogen and then injected with a lactogenic extract. Similar results were re-ported with mature non-ovulated ovariectomized rabbits. Nelson and Tobin (1936) were not able to secure any evidence of mammary growth in hypophysectomized rats with a pu rified lactogenic extract plus estrogen, but using a crude pituitary 'ex-tract a well developed gland was reported as being obtained. Gomez, Turner and Reece (1937) secured the first evidence that 
estrogen may cause the increased secretion by the pituitary of a factor which directly stimulates the mammary gland. They reported that the mammary glands of hypophysectomized guinea pigs could be stimulated to growth by the implantation of pituitaries from estrogen-injected donor rats. If the donor rats were not injected 
with estrogen, their pituitaries were ineffective in causing mam-mary growth. 
Of course it is well established that in most species of mammals estrogen will cause the development of a mammary duct system in the normal or castrate animal while progesterone plus estrogen is necessary to secure complete growth of the mammary gland. As to the necessity of a pituitary factor to explain mammary growth, the classical experiment has involved t he injection of estrogen or a combination of estrogen and progesterone into hypophysecto-miz·ed animals. If positive results were secured, it was claimed that it was unnecessary to postulate the mammary stimulating action of the pituitary. Conversely, if negative results were se-cured, the possible activity of the pituitary in stimulating mam-
mary growth was considered. The literature on this subject is both long and controversial, and it has been adequately reviewed by Turner (1939), Lewis and Turner (1939), and Riddle (1940) . 
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However, the first of a series of careful studies on the necessity 
of the intact pituitary to s€cure mammary growth with estrogen 
or estrogen and progesterone was reported by Reece, Turner and 
Hill (1936). Other reports soon followed (Gomez and Turner, 
1936) and Gomez, Turner, Gardner and HilI (1937) . These studies 
showed uniformly tha.t the ovarian hormones were ineffective 
in causing mammary growth iri the hypophysectomized animal. 
Selye, Collip and Thompson (1935) had concluded that because 
estrogen failed to maintain the mammary glands of six-day lactat-
ing hypophysectomized rats, a pituitary factor must be involved 
in mammary growth. This can hardly be considered a critical 
experiment because estrogen has not been shown to maintain the 
lactating mammary glands of non-suckled normal animals. 
These hypophysectomy studies plus the work demonstrating the 
effectiveness of pituitary material in the castrate or hypophy-
. sectomized-castrate animal led Gomez and Turner (1937, 1938a) 
to postulate that estrogen stimulates the .pituitary to secrete an 
increased amount of a mammogenic factor which causes duct 
growth. Estrogen plus progesterone was likewise believed to stimu-
late the pituitary to secrete an increased amount of a factor which 
causes lobule-alveolar growth. These pituitary factors were named 
mammogen duct growth factor and mammogen lobule-alveolar 
growth factor. 
Further evidence for the presence of mammogenic hormones in 
the anterior pituitary rapidly accrued. 
Fresh anterior pituitary tissue from pregnant cattle caused the· 
development of both ducts and alveoli in castrate rats. Anterior 
pituitary tissue from non-pregnant cattle was ineffective. Also 
fresh or acetone-dried anterior pituit ary tissue from pregnant cat-
tle caused complete development of mammary glands of ovari-
ectomized rabbits while rabbits receiving injections of non-pregnant 
pituitary tissue showed no growth (Gomez and Turner, 1938a) . 
Using the male mouse as an assay animal Gomez and Turner 
(1938b) also showed that estrogens in the form of anol, estradiol 
or a combination of the two greatly increased the duct growth 
promoting potency of donor rabbit pituitaries, indicat ing again that 
estrogen stimulates the pituitary to the increased production of a 
mammogenic factor. 
Nelson (1938a) was also able to confirm the presence of a mammo-
genic factor in the pituitary, securing duct and alveolar growth 
in hypophysectomized rats given an unfractionated pituitary ex-
tract plus estrogen. When pituitaries from estrogen-injected and 
normal rats were injected into hypophysectomized female rats, 
he observed no superiority of the estrogen-injected over the control 
pituitaries (1938b, 1939) thus failing to confirm the observation 
of Gomez and Turner (1938b) that estrogen will increase the 
pituitary mammogen content of donor animals. 
RESEARCH BULLETIN 378 7 
In a similar series of experiments Reece and Leonard (1939) 
also were unable to detect any superiority of est rogen-injected pituitaries over control pituitaries when injected into hypophy-
sectomized rats. The failure of Nelson, and Reece and Leonard to secure superior results with estrogen-injected donor rat pitui-
taries over controls is probably due to the insensitiveness of the hypophysectomized rat as compared for instance to the male 
mouse. 
Using the male mouse mammogenic duct growth factor assay (Fig. 1), Lewis and Turner (1939) reported an extensive series of 
studies on the mammogen content of various types of cat tle pitui-
taries. With adequate amounts of pituitary material available for assay and using a sensitive assay animal,' · it was found that 
varying amounts of mammogen were present in pituitaries of all types of animals, but that the concentration varied with the physi-
ological state of the animal. The st udies indicate the close cor-
relation between normal mammary growth and pituitary content 
of mammogen. They also found t hat by injecting male rabbits 
with estrone, the mammogen content of their pituitaries could be 
raised to double that found in pregnant rabbits. 
More recently Astwood (1941) has reported that whole pituitary powder caused lobule-alveolar proliferation of the mammary glands 
of pseudopregnant hypophysectomized rats. 
Reece and Leonard (1941) stat ed that an anterior pit uitary preparation containing growth hormone caused slight development 
of the mammary glands of hypophysectomized male rats while the 
extract plus estrogen was more effective. 
Using a purified lactogenic extract (35 I. U. per mg.) plus es-
trogen, Gardner and White (1941) secured slight duct growth in hypophysectomized male mice. 
Mammary gland growth in hypophysectomized rats was also se-
cured by Greep and Stavely (1941) with anterior pituitary tissue dessicated in vacuo. 
Gardner and White (1942) obtained rather poor mammary growth in hypophysectomized male mice with estrogen plus a commercial 
or a purified lactogenic extract and rather good mammary growth 
with estrogen plijs either a saline ext ract of pituitary or an adren-otropic hormone fraction. 
Gomez (1942) reported that duct growth was obtained in hypophy-
sectomized male and female guinea pigs by implanting or injecting 
macerated fresh anterior pituitary tissue of adult male or female guinea pigs. The minimal effective dosage was 20 mg. Slight mam-
mary growth was also obtained with a lactogenic extract. Growth 
was improved by using estrogen plus the. lactogenic extract. 
The daily injection of 300 micrograms of testosterone propionate p.lus 0.5 cc. growth hormone extract for fifteen days caus.ed lobule-
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alveolar growth in spayed hypophysectomized rats. The testos-
terone propionate alone was ineffective (Reece and Leonard, 1942). 
Lyons, Simpson and Evans (1942) secured minimal lobule-al-
veolar growth in hypophysectomized rats with 60 I. U. of lactogen 
plus 10 I. U. of estrone (or F. S. H.) daily for t~n days. Excellent 
lobule-alveolar growth was secured in hypophysectomized rats 
given daily injection of 10 I. U. of estrone. plus an anterior pituitary 
extract containing adrenotropic, growth as well as lactogenic hor-
mones. 
These reports of mammary duct and alveolar growth in castrate, 
hypophysectomized and castrate-hypophysectomized animals sup-
port the claim of Gomez and Turner (1937, 1938a) that there is a 
definite pituitary mammogen which directly stimulates mammary 
growth. 
2. Negative Results.-There are a considerable number of reports 
which indicate that mammary growth was not obtained with pitu-
itary materials. In reviewing these reports it was evident that the 
majority of ~hem were experiments on lactation, the mammary ob-
servations lieing rather incidental. Also in most instances the 
authors concerned have later reported experiments in which posi-
tive results have been secured with pituitary materials. Many 
negative results have been reported so because of the great diffi-
culty of judging mammary growth occurring simultaneously with 
mammary secretion. 
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EXPERIMENTAL SECTION 
As a result of experimental work already reviewed, Gomez and 
Turner (1937, 1938a) postulated that the ovarian hormone, estrogen, 
stimulates the pituitary to secrete an increased amount of a mam-
mogenic duct growth factor, while the ovarian hormones, proges-
terone and estrogen, stimulate the pituitary to secrete an increased 
amount of a mammogenic lobule-alveolar growth factor. These 
pituitary factors directly stimulate mammary gland growth. Lewis, 
Turner and Gomez (1939) developed an assay technic for the ma:m-
mogenic duct growth factor ('"Fig. 1) . In the following section are 
related the experiments resulting in the development of an assay 
method for the mammogenic lobule-alveolar growth factor. 
ASSAY OF MAMMOGENIC DUCT 
GROWTH· FACTOR 
THE MALE MOUSE HAS VERY R.UDIMENTAR.Y MAMMARY GLANDS. 
MALE MICE WEIGHING CONTROL GLAND STIMULATED GLAND 
15-2.5 GMS. ARE USED VERY R.UDIMENTAR.Y. GROWTH OF DUCTS 
WITH ENLARGED END BUDS. 
INJECTED SUBCUTANEOUSLY ONCE DAILY FOR. 6 DAYS. GLANDS. 
REMOVED ON 7TH DAY, FIXED, STAINED, AND EXAMINED FOR 
EVIDENCE OF GROWTH OF DUCTS. 
MOUSE UNIT-AMOUNT OF TISSUE OR EXT.RACT NECE SSARY 
TO SECURE I OR MORE GLANDS SHOWING GROWTH STIMULATION IN 50%± 10% OF TEN MALE MICE. 
Fig. 1.-The assay of the anterior pituitary mammogenic duct growth factor. 
A. Development of an Assay Method for the Mammogenic Lobule-
Alveolar Growth Factor 
1. Assay Animal.-The ovariectomized, virgin female mouse was 
selected tentatively as an assay animal because of its ·uncomplicated 
type of duct system (Turner and Gomez, 1933), its ability to respond 
to pituitary preparations with alveolar growth (Bradbury, 1932), 
and its small size, cheapness and ease of handling in large numbers. 
A photomicrograph of a mammary gland of a normal virgin female 
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mouse is shown in Fig. 2. It was observed that the first easily 
detectable signs of alveolar formation in pregnant mice consisted 
of the. proliferation of numerous side stubs and flowery ends on 
-~ 
2 
Fig. 2.-Whole mount of a check mammary gla nd from a normal 
virgin female mouse ( 14x). 
short interlobular ducts. This stage was taken as the criterion of 
minimal alveolar development for positive results in the assay 
method (Fig. 3), and it is similar to the condition present at four 
t,\ "' 
Fig. 3.-Whole muunt of a mammary gland of a young spaye'd virgin 
female mouse injected with one mg. of progesterone and 133 LU. of 
estrone over a ten-day period showing minimal alveolar developme'nt 
required for assay response (14x). 
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days of pregnancy. It is not present in normal female mice which 
have not been pregnant or pseudopregnant. Much greater alveolar 
development, however, is obtained at times (Fig. 4). 
4 
Fig. 4.-Whole mount of a mammary gland of a young spayed virgin female mouse injected for ten days with a total of 400 mg. of fresh 
anterior pituitary tissue secured from non-pregnant lactating cattle 
showing a more advanced development of the alveolar system than is 
re'quired for assay response (14x). 
In these studies check mammary glands were removed from all 
assay mice at the time of ovariectomy. Any development of the 
gland beyond a smooth duct system was cause for rejection of the 
mouse. A study of the relation of body weight of over 2000 mice 
to the rejection percentage was made (Fig. 5). It will be seen that 
if animals eighteen grams and under are selected, the number which 
must be discarded due to the presence of alveolar growth will be 
minimal. 
12 
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Fig. 5.- Relat ion of body weig ht to rejection percentage in v 1rg1n f emale mice. 
The percentage rejected because of lobule-alveola r develovment is fairly low (3-6 
per cent) up to 18 gm., above which weight the rejection perce ntage incre·ases 
sharply. Thus 18 gm. may be set as the upp er weight limit for assay mice. 
2. Methods and Materials.-The fresh cattle pituitaries used in 
these experiments were secured from Swift and Company of Kansas 
City. They were shipped in a frozen condition. The meninges and 
posterior lobes were removed arid t hen the anterior lobes ground 
four times through a fine meat chopper, refrozen· and st ored in 
sealed jars at a low temperature. Tissue for fresh injection was 
weighed out of the storage jars, mashed through an eighty-mesh 
screen with the assistance of a little water, diluted to a concen-
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tration of about 500 mg. per ml. of water and refrozen until it 
was ready for use. This stock material was diluted with water 
for injection purposes such that not over two-tenths ml. of liquid 
suspension was injected per mouse per day, preferably one-tenth 
ml. 
The mice were ovariectomized through an incision over the right 
abdominal mammary gland so that a mammary gland could be taken 
at the same time, as a check on the condition of mammary growth. 
A triangular piece of the subcutaneous fatty tissue fanning out 
laterally from the teat contains the mammary gland. This tissue 
containing the mammary gland was dissected out, pinned on a fiat 
cork and treated as described below for the entire glands. 
Unless otherwise stated, all injections were made once daily, ~nd the mice killed twenty-four hours after the last injection. 
The mice were slit down the center of the back and their skins re-
moved together with the subcutaneous fascia, pinned out on fiat 
sheets of cork and fixed in Bouin's solution. The subcutaneous 
fascia containing the glands was scraped from the skins, washed 
in water, stained in Mayer's hematoxylin and the mammary glands 
examined with a binocular dissecting microscope while differentiat-ing in seventy · per cent acid-alcohol. Turner and Gomez (1933) 
describe in more detail the process of preparing and mounting 
mouse mammary glands for examination. 
3. Mammary Lobule-Alveolar Growth with Anterior Pituitary 
Preparations Alone.-The following series of experiments were de-
signed to determine a suitable assay method for the mammogenic 
lobule-alveolar growth factor of the ant er ior pituitary using ovari-
ectomized virgin mice as the assay animal. Minimal development 
of the lobule-alveolar system was used as the criterion of positive 
response. 
Groups of mice were injected over periods of four, five, six or 
eight days with graded dosages of fresh pituitary tissue secured 
from pregnant cattle, designated Lot 5. The data show first that 
lobule-alveolar responses could be secured with this fresh anterior 
pituitary tissue over periods of injection ranging from four to 
eight days, no injection period appearing to have superiority over 
the others (Table 1). However, there was a poor correspondence between the dosages injected and the per cent positive mammary 
responses. 
As considerable numbers of positive alveolar r esponses were 
secured in the six-day injection period, it was decided to try new 
: groups of mice on a standard six-day injection hoping that more 
uniform results could be secured than was the case in the first 
experiments. Anterior pituitary preparations used in these trials 
included an acetone-ether dried fraction of Lot 5, Lot 6 fresh pitui-
tary from non-pregnant cattle, and Lots 7 and 8 fresh pituitary 
from pregnant cattle. Lobule-alveolar responses were secured with 
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TABLE 1. LOBULE-ALVEOLAR RESPONSES OF CASTRATE FEMALE 
MICE INJECTED FOR VARYING NUMBER OF DAYS WITH VARYING 
DOSAGES OF ANTERIOR PITUITARY PREPARATION 
Pituitary Preparation 
Name 
Lot 5, 
fresh 
anterior 
pituitary, 
pregnant 
cattle 
Total 
Dosage, 
Mg 
75 
100 
150 
200 
75 
100 
150 
200 
50 
60 
70 
75 
80 
90 
100 
110 
120 
130 
135 
150 
165 
180 
200 
210 
285 
50 
75 
100 
Days 
Injected 
4 
4 
4 
4 
5 
5 
5 
5 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
6 
8 
8 
8 
Number 
of Mice 
4 
12 
4 
4 
2 
4 
4 
4 
4 
4 
4 
4 
6 
6 
22 
12 
18 
9 
5 
9 
6 
7 
5 
6 
6 
4 
4 
4 
Lobule-Alveolar 
Responses 
+ Per Cent 
Posjtjye 
0 4 
5 7 
3 1 
1 3 
1 1 
1 3 
2 2 
3 1 
0 4 
0 4 
0 4 
3 1 
1 5 
0 6 
6 16 
1 11 
6 12 
0 9 
5 0 
5 4 
6 . 0 
6 1 
3 2 
1 5 
6 0 
0 4 
0 4 
2 2 
0.0 
41. 7 
75.0 
25.0 
50.0 
25.0 
50. 0 
75.0 
0.0 
0.0 
0.0 
75.0 
16. 7 
0.0 
27.3 
8.3 
33.3 
0.0 
100.0 
55.6 
100.0 
85. 7 
60.0 
16.7 
100.0 
0.0 
0.0 
50.0 
the Lot 5 acetone-ether dried fraction, indicating that the mammo-
genic factor is proteinaceous in nature (Table 2). No mammary 
growth was secured with Lot 6 fresh pituitary from non-pregnant 
cattle even in doses as high as 600 mg: showing that non-pregnant 
pituitaries are low in this factor. Positive responses were ·secured 
with both Lots 7 and 8 fresh. anterior pituitary from pregnant 
cattle. In these series of experiments, as in the last, the dosages 
of extract injected corresponded poorly with the per cent positive 
mammary responses. 
In a further attempt to secure better correspondence between 
the dosage of pituitary preparation injected and the per cent 
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TABLE 2. LOBULE-ALVEOLAR RESPONSES OF CASTRATE FEMALE MICE INJECTED FOR SIX DAYS WITH ANTERIOR PITUITARY 
MATERIALS . 
:eitl!ii!l.!:ll Prei;iarnUQn Lobule-Alveolar 
Total Days Number Resr;iQnses Name Dosage, Injected of Mice + Per Cent 
Mg. Positive 
Lot 5, 45 6 4 1 3 25.0 
acetone- 60 6 4 1 3 25.0 
ether dried 75 6 4 2 2 50.0 
anterior 90 6 4 1 3 25.0 pituitary, 
pregnant 
cattle 
Lot 6, 200 6 4 0 4 0.0 fresh 400 6 4 0 4 0.0 
anterior 600 6 4 0 4 0.0 
pituitary, 
non-pregnant 
cattle 
Lot 7, 50 6 4 0 4 0.0 fresh 100 6 4 0 4 0.0 
anterior 150 6 8 0 8 0.0 pituitary, 200 6 7 0 7 0.0 pregnant 250 6 4 4 0 100.0 
cattle 280 6 4 3 1 75.0 
Lot 8, 100 6 6 1 5 16. 7 fresh 150 6 12 4 8 33.3 
anterior 200 6 12 7 5 58.3 pituitary, 250 6 12 5 7 41.7 pregnant 300 6 6 0 6 0.0 
cattle 
15 
positive mammary response, other groups of mice were injected 
over a ten-day period using Lot 8 acetone-ether dried pituitary 
from pregnant cattle, Lots 8, 9, 10, and 11 fresh pituitary from 
pregnant cattle and Lot 12 fresh anterior pituitary from lac-
tating cattle. Again, there was a poor relation between the dosage 
of material injected and the per cent positive mammary responses (Table 3). · 
The results of these three series of experiments showed that 
pituitary materials alone do have the ability to stimulate mammary 
lobule-alveolar growth. Of 630 mice, 144 or 22.9 per cent responded 
with mammary growth to pituitary . injections. However, the cor-
respondence between the doses of pituitary · preparations injected 
and the per cent positive mammary responses was very poor, show-
ing that some variable was still missing or uncontrolled; The·se data 
were secured in ovariectomized mice in which the normal supply of 
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TABLE 3. LOBULE-ALVEOLAR RESPONSES OF CASTRATE FEMALE 
MICE INJECTED FOR TEN DAYS WITH ANTERIOR PITUITARY 
MATERIAL 
Pituitary Preparation 
Name 
Lot 8, 
fresh 
anterior 
pituitary, 
pregnant 
cattle 
Lot 8, 
acetone-
ether dried 
anterior 
pituitary, 
pregnant 
cattle 
Lot 9, 
fresh 
anterior 
pituitary, 
pregnant 
cattle 
Lot 10, 
fresh 
anterior 
pituitary, 
pregnant 
cattle 
Lot 11, 
fresh 
anterior 
pituitary, 
pregnant 
cattle 
Lot 12, 
fresh 
anterior 
pituitary, 
lactating 
cattle 
Total 
Dosage, 
M~. 
100 
150 
200 
250 
300 
333 
25 
50 
75 
100 
125 
150 
200 
250 
300 
350 
400 
100 
200 
300 
400 
100 
200 
300 
400 
300 
350 
400 
Days 
Injected 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
10 
Number 
of Mice 
5 
5 
5 
5 
5 
5 
6 
6 
5 
6 
6 
29 
28 
39 
36 
24 
21 
5 
20 
19 
6 
5 
5 
16 
6 
8 
6 
8 
Lobule-Alveolar 
Responses 
+ 
0 5 
0 5 
0 5 
1 4 
1 4 
5 0 
0 6 
0 6 
0 5 
1 5 
0 6 
5 24 
5 23 
9 30 
4 32 
8 16 
5 16 
0 5 
5 15 
3 16 
2 4 
1 4 
0 5 
4 12 
2 4 
3 5 
1 5 
4 4 
Per Cent 
Positive 
0.0 
0.0 
0.0 
20.0 
20.0 
100.0 
0,0 
0.0 
0.0 
16. 7 
0.0 
17.2 
17.9 
23.1 
11.1 
33.3 
23.8 
0.0 
25.0 
15.8 
33.3 
20.0 
0.0 
25.0 
33.3 
37.5 
16. 7 
50.0 
endogenous estrogen is very low or entirely lacking. Consequently, 
it was reasoned that the endogenous estrogen might play some 
secondary role in mammary growth (other than stimulating a 
pituitary duct growth factor) which had not been appreciated. 
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The following sect ion describes a series of experiments concerning 
a possible secondary role of estrogen in stimulating mammary 
gland growth. 
4. Mammary Lobule-Alveolar Growth with Anterior Pituitary 
Preparations Plus Estrogen.-Several investigators have demon-
strated that estrogen enhances the ability of pituitary extracts 
to cause mammary growth. Nelson (1938b) reported that when hypophysectomized rats received estrogen in addition t o rat pitui-
taries, better mammary growth was secured than when rat pitui-
taries alone were given. 
Mixner . and Turner (1941a) suggest ed in preliminary report 
that estrogen enchances the activity of pituitary extracts in pro-
moting mammary growth through its hyperemic and permeability-increasing action on the vascular system of stromal tissue surround-
ing the mammary gland. Further evidence that this is t he case 
was presented in a later report (1942). 
Gardner and White (1941) reported that estrogen plus a lac-
togenic extract was more effective in causing mammary gland growth 
in hypophysectomized male mice than was lactogen alone. They 
concluded that estrogen sensitizes the mammary gland to the action 
of lactogen. 
Growth hormone extract alone produced slight growth of the mam-
mary gland in hypophysectomized male rats while estrogen plus 
growth hormone ext ract was more effective (Reece and Leonard, 1941). 
Gomez· (1942) also secured slight mammary growth in hypophy-
sectomized-castrate guinea pigs with a lactogenic extract. This 
growth was improved when estrogen was given in addition t o the lactogenic extract. 
Gardner and White (1942) found that estrogen plus either a 
commercial lactogenic extract, a more purified lactogenic extract, 
a saline extract of pituitary or a good adrenotropic extract gave 
mammary growth in hypophysectomized male mice, t he pituitary hormones alone in the dosages given being ineffective. · 
These reports indicate that estrogen has some special enhanc-
ing effect on the activity of pituitary preparations in causing mam-
mary growth. 
a. Experimental. In this series of experiments groups of assay 
animals were injected with either of two pituitary preparations 
alone, while other groups received a t otal of 75 I. U. of est rone ·in 
addition to the pituitary preparations (Table 4). Typically poor 
iresults were secured with both Lot 13 fresh pituitary from stock-
' yard run of cattle and an initial extract of Lot 13 when they were 
injected without estrogen. With 50 mg. of Lot 13 fresh pituitary 
plus estrone, eight out of thirteen (62 per cent) mice gave posi-
tive responses, while .with 100 mg:, 100 per cent of thirteen mice 
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gave positive responses. This is in contrast to two out of eight 
(25 per cent) positive responses with 400 mg. of Lot 13 fresh pitui-
tary injected alone. Similar results were secured with the initial 
extract of Lot 13. With this extract at a dosage of 7.5 mg., three 
of six mice responded with lobule growth when estrone was also 
given, a 50 per cent positive response. Another group of eleven 
mice gave six positive responses with 7.5 mg. of extract plus es-
trogen while still a third group of eighteen mice gave nine posi-
tive responses, a 50 per cent positive response. 
These results (Table 4) show that by the use of a small amount 
of estrone in conjunction with pituitary mammogenic preparations, 
the dosage of pituitary required for an assay response was greatly 
reduced as compared to pituitary extract injected without estrone. 
Also graded mammary responses could be secured that corresponded 
to the graded pituitary dosages injected. These two factors, sen-
sitiveness of assay animals to relatively small dosages of pitui-
tary extract and the graded positive responses of animal assay 
groups to graded pituitary dosages, make the use of estrogen with 
pituitary materials very desirable in an assay method for this mam-
mogenic factor. 
TABLE 4. LOBULE-ALVEOLAR RESPONSES OF CASTRATE FEMALE MICE 
INJECTED FOR TEN DAYS WITH VAR YING DOSAGES OF ANTERIOR 
PITUITARY MATERIAL WITH AND WITHOUT ESTRONE 
Pitl.litiri Erf:llil:iUQn Estrone, Lobule-Alveolar 
Total Total Days Number R!lSllQllS!lS 
Name Dosage, Dosage, Injected of Mice + Per Cent 
Mg. I.U. Positive 
Lot 13, fresh 100 10 6 1 5 16.7 
anterior pituitary, 200 10 5 1 4 20.0 
stockyard run of 300 10 5 1 4 20.0 
cattle 400 10 6 2 4 33.3 
50 75 10 13 8 5 61.5 
100 75 10 13 13 0 100.0 
Lot 13, initial 5.0 10 5 0 5 0.0 
extract of anterior 10.0 10 5 0 5 0,0 
pituitary from stock-15. 0 10 4 0 4 0.0 
yard run of cattle 20.0 10 5 1 4 20.0 
25.0 10 4 0 4 0.0 
50.0 10 4 0 4 0.0 
7.5 75 10 6 3 3 50.0 
7.5 75 10 11 6 5 54.5 
7.5 75 10 18 9 9 50.0 
10.0 75 10 21 12 9 57.1 
12.5 75 10 23 20 3 87.0 
17.5 75 10 34 33 1 97.1 
RESEARCH BULLETIN 378 19 
Estrone, alone, injected into the assay animals in doses over 
five times as high as those used with the pituitary materials (Table 
4) produced no signs of lobule growth, confirming a similar ob-
servation of Turner and Gomez (1934). 
With the development of the use of estrogen in the assay proce-
dure, it was desirable to reinvestigate the proper length of time for the injection period. Accordingly groups of mice were injected for four, six, eight, ten, fifteen, and twenty days with 17.5 mg. 
of Lot 15 acetone-ether dried anterior pituitary of pregnant cattle 
plus 75 I. U. of estrone. With the twenty-day group, the estrone 
dosage was doubled over that of the other five groups (Table 5). 
TABLE 5. LOBULE-ALVEOLAR RESPONSES OF CASTRATE FEMALE MICE INJECTED FOR VARYING NUMBER OF DAYS WITH A CONSTANT DOSAGE OF ANTERIOR PITUITARY MATERIAL PLUS ESTRONE 
Eib.litarl!'. EreiiaratiQn Estrone Lobule-Alveolar Total Total Days Number Resii2nses Name Dosage,Dosage, Injected of Mice + Per Cent 
Mg. I. U. Positive 
Lot 15, acetone- 17.5 75 4 13 0 13 o.o 
ether dried anterior 17.5 75 6 13 4 9 30.8 pituitary from 17.5 75 8 12 6 6 50.0 pregnant cattle 17.5 75 10 13 9 4 69.2 
17.5 75 15 15 9 6 60.0 
17.5 75 20 15 8 7 53.3 
17.5 150 20 15 10 5 66. 7 
The per cent positive responses increased as the number of days injection was lengt'hened up to the ten-day injection period where 
the per cent positive responses were highest. Thus the ten-day 
injection period appeared to be optimal under the assay conditions. 
Still another factor investigated was the effect of the length of 
time after the mice were ovariectomized before injections were· begun, on the lobule-alveolar responses. Groups of mice were in-jected over a ten-day period with 20 mg. of Lot 15 acetone-ether dried ~nterior pituitary from pregnant cattle starting one, five, 
ten, twenty, thirty, forty and fifty-five days respectively after 
ovariectomy (Table 6). The group ovariectomized fifty-five days 
received 7;5 I. U. of estrone ·per day over the last five days of this 
period. Positive lobule-alveolar responses decreased in an orderly 
manner from 84.6 per cent for the one-day ovariectomized group 
to 16.7 per cent for the forty-day ovariectomize<l group. However, 
the group ovariectomized for fifty-five days and which received 7.5 
I. U. of estrone per day over the last five days gave assay results 
comparable with the one-day ovariectomized group, showing that 
the effects of ovariectomy can be overcome by this procedure. 
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TABLE 6. THE EFFECT OF THE TIME AFTER OVARIECTOMY AND BEFORE 
INJECTIONS BEGAN ON LOBULE-ALVEOLAR RESP<?NSES 
Ei111itary Pr~uiaration Estrone, Days Lobule-Alveolar 
Total Total Ovariect Number Resi;ionses 
Name Dosage, Dosage, Before of Mice + Per Cent 
Mg. I. u. Injected Positive 
Lot 15, acetone- 20 75 1 13 11 2 84.6 
ether dried 20 75 5 13 9 4 69.2 
-anterior pituitary, 20 75 10 13 7 6 53.8 
pregnant cattle · 20 75 20 12 5 7 41.7 
20 75 30 13 4 9 30.8 
20 75 40 12 2 10 16.7 
20 75 55* 11 10 1 90.9 
*Last five days ea.ch mouse received 7.5 I. U. of es trone per day. 
Thus from the viewpoint of the accuracy and sensitivity of the 
assay, the mice should be started on assay-injections immediately 
after ovariectomy or else be given preliminary estrogen injections. 
5. The Assay Technic. · As a result of the first six series of ex-
periments (Tables 1-6) sufficient information was at hand to form-
ulate an essay technic for the mammogenic lobule~alveolar growth 
factor. It was found that minimum mammary lobule-alveola,r growth 
responses in ovariectomized virgin female mice (12-18 gm.) were 
directly prqportional to the dosage of anterior pituitary prepara-
ASSAY OF THE MAMMOGENIC LOBULE -
ALVEOLAR GROWTH FACTOR 
A~ ~RMONE ~ER~ "ru~ 
CASTRATE, NUUJ PAROUS 
FEMALE MICE WEIGHING 
12-18 GRAMS ARE USED. 
CONTROL GLAND REMOVE.D STIMULATED GLAND, 
AT TIME OF OVARIECTOMY LOBULE-ALVEOLAR 
SHOWS DUCT SYSTEM ONLY. GROWTH COMPARABLE 
TO 4 - 8 DAYS 
PREGNANT GLAND. 
MICE INJECTED SUBCUTANEOUSLY ONCl DAILY FOR 10 DAYS WITH ASSAY MATERIAL. SIMULTANEOUS DAILY INJECTION Of. 7.5 1.U. OF ESTF\ONE. GLANDS REMOVED ON THE 
11TH DAY, FIXED, STAINED AND EXAMINED FOR LOBULE -ALVEOLAR GROWTH. 
MOUSE UNIT -AMOUNT OF MATERIAL REQUIRED PER MOUSE TO OBTAIN 
LOBULE-ALVEOLAR GROWTH IN 50% ± 103 OF TEN CASTRATE NULLIPAROUS 
FEMALE MICE. WHEN ESTRONE IS SIMULTANEOUSLY INJECTED. 
Fig. 6.-The assay of the anterior pituitary mammogenic lobule-alveolar growth factor. 
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tion injected if a small amount of est rone was simultaneously 'in-jected. The highest percentage of positive responses was secured 
with a given dose of pituitary preparation and estrone in a ten-day injection period. Also it was found that assay mice should be started on injections immediately after ovariectomy in order 
that accurate and sensitive assay results may be secured. Accordingly, an assay technic was formulat\'d (Fig. 6) . A mouse 
unit of the mammogenic lobule-alveolar growth factor is defined as the amount of material required per mouse injected over a period 
of ten days to obtain minimal mammary lobule-alveolar growth in 50 ± 10 per cent of ten or more castrate nulliparous female mice 
when a total of 75 LU. of estrone is simultaneously injected. The role that estrogen apparently played in the st imulation of 
mammary lobule-alveolar growth in these experiments seemed es-pecially significant. Therefore a study was made in an effort to discover the means by which estrogen exerted this special effect in lobule growth. 
B. The Role of Estrogen in the Stimulation of Mammary Lobule-
Alveolar Growth 
1. Review of Literature.-An extensive literature has developed in regard to the synergism of estrogen and progesterone in their 
actions on the various sexual processes with which they ar e asso-
ciated. Corner and Allen (1929), Hisaw and ,Leonard (1930), Allen (1930, 1932), and Leonard, Hisaw and Fevold (1932), as well as 
many others, have demonstrated this synergism on t he growth of the endometrium. 
Weichert (1928) demonstrated that a "1-2" relationship exists between "estrogen and progesterone in causing the decidual reaction in the uterus of the rat and guinea pig. 
Dempsey, Hertz and Young (1936) and Hertz, Meyer and Spiel-
man (1937) showed that female guinea pigs pretreated with est rogen 
and injected with progesterone displayed the copulatory reflex when the appropriate stimulus was applied. · 
Turner (1939) reviewed a voluminous literature showing that in 
most species of animals a combination of estrogen and progest erone is necessary to secure complete mammary growth, estrogen or progesterone alone being insufficient at the dosage level adminis-tered. Lyons and McGinty (1941) and Scharf and Lyons (194+) have more recently demonstrated the quantitative relationships 
existing between progesterone and estrogen in stimulating mammary gland growth in the male rabbit. On the other hand, Selye (1940a, 1940b), Selye, Borduas and Masson (1942) and Reece and Bivens (1942) have reported that progesterone alone in high dosages will 
cause complete mammary growth in ovariectomized rats. Hartman 
and Speert (1941) made a similar observation in ovariectomized 
monkeys. · 
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The review and experimental data presented in the previous 
section shows that estrogen also enhances the ability of pituitary 
preparations to stimulate mammary growth. 
In attempting to further determine the quantitative and quali-
tative relationships existing between estrogen and progesterone 
in causing alveolar growth, the following experiments were con-
ducted. 
2. Experirnental.-In these experiments progesterone and a pro-
gesterone-like compound, pregneninolone, were substituted for the 
pituitary preparation in the general framework of the assay method 
as described in the preceding section. Both pituitary preparations 
and progesterone-like compounds may be assayed for their ability 
to stimulate lobule-alveolar growth using this assay method. 
Estrone constant, progesterone varied.-In the . first experiment 
groups of , mice were injected with a constant amount of estrone 
over the ten-day assay period while the amount of progesterone 
was varied in different groups from 25 to 1500 micrograms (Table 
7). It will be seen that an assay dose of progesterone (plus 133 
I. U. of estrone) was approximately 875 micrograms, the responses 
being directly proportional to the dose of progesterone injected. 
TABLE 7. LOBULE-ALVEOLAR RESPONSES OF CASTRATE 
FEMALE MICE iNJECTED FOR TEN DAYS WITH VAR YING 
AMOUNTS OF PROGESTERONE AND A CONSTANT AMOUNT 
OF ESTRONE 
Progesterone, Estrone, Lobule-Alveolar 
Total Total Number BesgQnses 
Dosage, Dosage, of Mice + Per Cent 
Micrograms I. u. Positive 
25 133 4 0 4 0.0 
50 133 4 0 4 0.0 
125 133 4 0 4 0.0 
250 133 4 0 4 0.0 
500 133 16 4 12 25.0 
750 133 12 5 7 41.6 
1000 133 10 6 4 60.0 1250 133 12 10 2 83.3 1500 133 3 3 0 100.0 
Estrone varied, progesterone constant.-In the second experiment 
the progesterone was kept constant at one mg., slightly above the 
assay dose, while the estrone was varied in amount for the ten-
day period from 10 I. U. to 2400 I. U. per mouse (Table 8). In the 
range of estrone injections of 40 I. U. to 133 I. U., optimal syner-
gism was observed. Below 40 I. U. the estrone was insufficient 
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for optimal synergism with one mg. of progesterone. When the 
estrone was increased to 1200 and 2400 I. U. respectively, the syner-
gism was again reduced. The estrone appeared to override the 
progesterone activity in these cases such that little or no mammary 
growth resulted. 
TABLE 8. LOBULE-ALVEOLAR RESPONSES OF CASTRATE 
FEMALE MICE INJECTED FOR TEN DAYS WITH A 
CONSTANT AMOUNT OF PROGESTERONE, BUT VARYING 
AMOUNTS OF ESTRONE 
Progesterone, Estrone, Lobule-Alveolar 
Total Total Number R!:SJ;!QllS!:lS 
Dosage, Dosage , of Mice + Per Cent 
Microg:rams I. u. Positive 
1000 10 10 2 8 20.0 
1000 40 10 6 4 60.0 
1000 70 11 7 4 63.6 
1000 100 11 6 5 54.5 
1000 133 10 6 4 60.0 
1000 1200 9 3 6 33.3 
1000 2400 9 0 9 0.0 
Progesterone alone.-Graded doses of progesterone alone were given 
to groups of assay animals in the third experiment (Table 9). The 
results demonstrate quantitatively the greatly increased amount of 
progesterone required to secure mammary lobule-alveolar growth 
when estrogen is not given in conjunction with the progesterone. 
The assay animals were ovariectomized about ten days previous 
to the start of progesterone injections so that endogenous estrogen 
was largely eliminated from their system. Approximately six times 
as much progesterone alone was required to secure a unit response 
as was required in the first experiment (Table 7) when estrone 
was injected with the progesterone. 
TABLE 9. LOBULE-ALVEOLAR RESPONSES OF CASTRATE 
FEMALE MICE INJECTED FOR TEN DAYS WITH VARYING 
AMOUNTS OF PROGESTERONE ALONE 
Progesterone, Lobule-Alveolar 
Total Number R!:Sl;!QllS!:S 
Dosage, of Mice + Per Cent 
Mg. Positive 
3.33 24 2 22 8.3 
4.67 24 5 19 20.8 6.00 26 15 11 57.7 
7.33 24 17 7 70.8 
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Pregneninolone with and without estrone.-It was interesting to 
determine whether a compound related to progesterone in its ac-
tivity had a similar synergism with estrogen. This compound, preg-
neninolone (anhydro-hydroxy-progesterone or ethinyl testosterone), 
known to have progesterone-like act ivity (Emmens and Parkes, 
1939), was injected both with and without estrone in groups of mice 
(Table 10). Pregneninolone with estrone required about two mg. 
for an assay response while pregneninolone alone required about 
ten mg. This ratio of one to five of pregneninolone with and with-
out estrone compares very closely to the one to six ratio of proges-
terone with and without estrone. 
TABLE 10. LOBULE-ALVEOLAR RESPONSES OF CASTRATE 
FEMALE MICE INJECTED FOR TEN DAYS WITH VARYING 
AMOUNTS OF PREGNENINOLONE WITH AND WITHOUT 
ES TRONE 
Pregneninolone, Estrone, Lobule-Alveolar 
Total Total Number Rfl::il;!QilSfl::i 
Dosage, Dosage, of Mice + Per Cent 
Mg, I. u. Positive 
1. ci 133 12 1 11 8.3 
1.5 133 12 3 9 25.0 
2.0 133 12 7 5 58.3 
2.5 133 10 9 1 90.0 
5.0-10.0 133 12 12 0 100.0 
2.5 4 0 4 0.0 
5.0 6 0 6 0.0 
7.5 8 2 6 25.0 
10.0 12 5 7 41. 7 
12.5-20.0 16 16 0 100.0 
These experiments are especially interesting and significant when 
compared to the experiments (Tables 1-6) with pituitary mammary 
growth preparations with and without estrone. It appears that the 
pituitary factor which directly stimulates alveolar growth needs 
the accompanying action of estrogen to the same extent as does 
progesterone, the indirect stimulator of alveolar growth. 
It is interesting to note that 2400 I. U. of estrone was able to 
completely inhibit the normal unit response of one mg. of proges-
terone (Table 8). It is probable that the pituitary was adversely 
affected by the large dose of estrone. In Table 11 is presented a 
similar experiment with a unit of pituitary material, given in one 
case with 75 I. U. of estrone and in the other with 2400 I. U. of es-
trone. Due to the direct action of the injected mammogenic factor, the 
large dose of estrone was unable to inhibit the normal unit response 
of the pituitary extract. 
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TABLE 11. LOBULE-ALVEOLAR RESPONSES OF CASTRATE FEMALE 
MICE INJECTED FOR TEN DAYS WITH A CONSTANT AMOUNT OF ANTERIOR PITUITARY MATERIAL AND A HIGH AND LOW AMOUNT 
OF ESTRONE 
EitYi1Uli'. Er!l!2s[atiQn Estrone, Lobule-Alveolar 
Name Total Total Number Res12onses 
Dosage, Dosage, of Mice + Per Cent Mg. I. u. Positive 
Lot 15, 
acetone-
ether dried 15 75 14 8 6 . 57.1 
anterior 
pituitary, 15 2400 12 7 5 58.3 pregnant 
cattle 
25 
Substitution of other estrogens for estrone.-Both estradiol benzoate 
and diethylstilbestrol may replace estrone as an estrogen in con-junction with progesterone to secure mammary lobule-alveolar 
growth (Table 12). Without doubt other estrogens as well could 
be substituted satisfactorily for estrone. 
TABI.;E 12. LOBULE-ALVEOLAR RESPONSES OF CASTRATE FEMALE MICE INJECTED FOR TEN DAYS WITH A CONSTANT AMOUNT OF PROGESTERONE 
BUT WITH DIFFERENT ESTROGENIC COMPOUNDS 
Progestrone Estx:ai:~nic CamtHll.1nds 
Total Total Number Lobule-Alveolar Dosage, Name Dosage, of B£sgons~s Mg. Micrograms Mice + Per Cent 
Positive 
Estrone 7.5 9 5 4 55.5 
Estradiol Benzoate 5.0 11 6 54.5 
Diethylstilbestrol 25.0 12 7 58.3 
Ovariectomy and estrogen on mammary glands.-From Table 6 'it 
is seen that mammary. lobule-alveolar responses decreased as a re-
sult of delaying the start of pituitary injections after ovariectomy. 
It was interesting, therefore, to compare the appearance of mam-
mary glands and the surrounding stromal tissue of a group of mice 
ovariectomized 62 days with another group also ovariectomized 62 
days, but injected for the last five days with a total of 37.5 I. U. 
of estrone. 
The mammary gland fat pads of the two groups of mice were 
examined after the mice were skinned. The group of animals 
ovariectomiz·ed but not ·receiving estrogen had white fat pads in 
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which the mammary glands were located, indicating poor vascularity 
of the gland. End buds were lacking on the mammary glands and 
the ducts were thin and regressed to some extent. The uteri of these 
animals were also atrophic as would be expected. The est rogen-
treated group of ovariectomized. mice, on the other hand, showed 
a deep pink coloring of the stromal tissue surrounding the mam-
mary glands, indicating good vascularity: Also the mammary glands 
showed developing end buds and normal ducts. The uteri of these 
animals were hypertrophied. 
These observations taken in conjunction with the other experi-
ments involving the need of estrogen with pituitary mater ials or 
progesterone in promoting mammary lobule-alveolar growth, sug-
gested the means by which estrogen enhances mammary growth. 
3. Discussion.-Lyons and McGinty (1941) and Scharf and Lyons 
(1941) conducted experiments on mammary gland growth in male 
rabbits and determined that one mg. of progesterone synergized 
best with about 240 I. U. of estrone. These results are in accord 
generally with those recorded in Tables 7 and 8. Apparently the 
range of estrogen that will synergize with a given dosage of pro-
gesterone is quite wide, but an estrogen dose which is too high or 
too low will adversely effect mammary gland growth as shown by 
data recorded in Table 8. Gardner (1941a) was able to inhibit 
mammary gland growth with large amounts of estrogen in male 
mice, immature female and male monkeys, and female dogs. As 
seen in Table 8 of this paper, 2400 I. U. of estrone inhibited com-
pletely the activity of one mg. (one mouse unit) of progesterone, 
but this same estrone dosage was unable to inhibit the activity of 
fifteen mg. (one mouse unit) of a pituit ary extract (Table 11). It 
would appear from this comparison that the inhibitory action of 
estrogen on progesterone is mediated through the pituitary, the 
high estrogen dosage causing the pituitary to be unresponsive to the 
progesterone stimulation. As shown by the experiment with pitui-
tary plus high estrogen dose (Table 11), estrogen does not inhibit 
the capacity of the mammary glands as end organs to respond. 
Progesterone alone (Table 9) and ·pituitary materials alone 
(Tables 1-6) caused mammary lobule-alveolar growth. Much smal-
ler quantities of these materials were necessary if estrogen was 
supplied (Tables 4, 7) . This indicates that estrogen has some 
common action with both progesterone and pituitary preparations 
in promoting lobule-alveolar growth. It appears that this action 
is not mediated through the pituitary, but rather at the site of mam-
mary growth. 
A theory that explains this activity of estror,en is that estrogen 
acts directly on the stromal tissue surrounding the mammary gland 
producing an increased hyperemia and vascularity associated with 
an increased permeability of the vascular system. By this action 
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of estrogen, more rapid growth of the mammary gland is promoted indii:ectly by increasing the amount of pituitary mammogen in the intercellular spaces in the region of the mammary gland and also by increasing the amount of nutrients available to the growing gland. This theory has been advanced in a preliminary paper by lYiixner and Turner (1942). 
In evaluating the literature which has a bearing on this subject it must be appreciated that the mammary gland is a sexual organ and changes occurring in it are associated with similar changes occurring in other sexual organs or glands. Hechter, Lev and Soskin (1940) pointed out that the effects of estrogen may be divided into specific effects which are not dependent on its hyperemic action and those which are non-specific and may be, therefore, associated with the acetylcholine-liberating action of estrogen. Reynolds and Foster (1940) and Riddle (1941) have reviewed these secondary, non-specific effects of estrogen. MacLeod and Reynolds (1938) and Reynolds (1939a, 1939b, 1941) reported that the initial hyperemia of the uterus following estrogen administration is accompanied by an increase in its acetylcholine content. As blood vessels dilated they also became more perme-able and an accumulation of water took pla·ce in the tissue. These same authors and also Kerly (1940) observed an increased metabo-lism of the uterus following estrogen administration. Hechter, Krohn and Harris (1941) found that estrogen caused an increased permeability of uterine blood vessels to trypan blue injected in-travenously. Freed and Lindner (l!l41) reported that estrone in-creased the capillary permeability of abdominal skin of rabbits while Reynolds and Foster (1940) observed capillary and venule dilation in rabbit ears, caused by estrogen. Chamberlin, Gardner and Allen (1941) applied estrogen cutane-ously to the sexual skin and breasts of male monkeys and secured local vascular responses of edema and hyperemia in each instance. Speert (1941), also studying the monkey, found definite cyclic changes in the mammary gland associated with an ovulatory cycle. There was lobular dilation and enlargement accompanied by an increased vascularity of the gland. Similar observations on the effect of estrogen on the vascularity of the mammary gland stromal tissue were reported in the experimental section. These effects of estrogen are suggested as the explanation for the enhancing action of estrogen on progesterone and pituitary extracts secured in the experiments already reported and also se-cured by other investigators. Increased vascularity and permea-bility of the vascular system would greatly increase the efficiency of action of a circulating pituitary mammogen. These effects of estrogen may also explain how local growth of the mammary gland has been secured by the percutaneous appli-cation of estrogen (J adassohn et al., 1937; Zondek, 1938; Mac Bryde, 
28 MISSOURI AGRICULTURAL EXPERIMENT STATION 
1939; Lyons and Sako, 1940; Speert, 1940a; Gardner, 1941b; Nelson, 
1941a; and Lewis and Turner, 1942a). Pituitary mammogen, which 
was circulating in the blood stream in subminimal or minimal 
amounts for mammary growth, would find a localized hyperemic 
and edematous condition at the site of percutaneous application 
of estrogen. This would allow the circulating mammogen to be 
maximally effective. That a circulating pituitary mammogen is 
necessary for local mammary gland growth is suggested by the 
experiments of Gomez (1941) and Leonard and Reece (1942) who 
found that doses of estrogen which were effective in normal ani-
mals in promoting local growth of the mammary gland were 
ineffective in causing such growth when the animals were hypophy-
sectomized. 
C. The Relation of the Mammogenic Lobule-Alveolar Growth 
Factor to Other Anterior Pituitary Hormones. 
1. Review of Literature.-Gomez and Turner (1937, 1938a), both 
on the basis of the normal physiology of mammary gland growth 
and on the basis of hypophysectomy and replacement therapy ex-
periments, have postulated the secretion by the pituitary of two 
mammogenic factors, a duct growth factor, stimulated to increased 
secretion by estrogen, and a lobule-alveolar growth factor, stimu-
lated to increased secretion by progesterone and estrogen. 
From the viewpoint of mammary gland growth, it is of consider-
able importance to know the exact nature of the pituitary factors 
or factor which are responsible for mammary gland growth. Are 
there specific pituitary mammogenic factors which are different 
from the identified or known pituitary factors? Are these mammary 
growth affects due to several known pituitary factors or to a single 
known factor? The definite solution of these questions awaits fur-
ther research on the subject. 
A priori considerations would indicate that the lactogenic hormone 
is not responsible for mammary lobule-alveolar growth, as several 
studies (Reece and Turner, 1937, and Holst and Turner, 1939) have 
already indicated that the pituitary secretion of the lactogenic 
hormone during pregnancy does not rise appreciably above the 
level of the non-pregnant animal until parturition after which, or 
at this time, it rises very sharply. Thus, lobule-alveolar growth 
occurs at a time during pregnancy when there is no . significant 
rise in the level of the lactogenic hormone secretion of the anterior 
pituitary. 
Gomez and Turner (1937) have reviewed some of the earlier papers 
on the effect or non-effect of lactogenic extracts on mammary 
growth. These reports are rather controversial, but not very sig-
nificant as regards the question of the possible identity of the lac-
togenic and mammogenic hormones due to the relative crudeness 
of the earlier extracts. These authors report that they secured no 
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mammary growth in hypophysectomized guinea pigs with lactogenic, thyrotropic or adrenotropic extracts, with or without estrogen, in-dicating that these hormones were not the active pituitary mam-
mary growth hormones. · 
Nelson (1941b) reported that an adrenotropic extract of the pitui-tary caused slight to marked mammary growth in immature male and female rats or in castrate and hypophysectomized rats. Astwood (1941) found that a crude pituitary powder caused marked proliferation of the lobule-alveolar system of hypophy-sectomized-pseudopregnant rats. Lactogenic-adrenotropic frac-tions caused little or no proliferation. Although some luteotrophic extracts caused lobule formation, there was no correlation between corpus luteum formation and mammary growth. Gomez (1942) secured slight mammary growth in hypophysecto-mized castrate guinea pigs with a lactogenic extract, which was im-proved by the simultaneous injection of estrogen. Using hypophysectomized male ·mice Gardner and White (1942) secured mammary growth with estrogen plus a commercial lacto-genic extract, a purified lactogenic extract, a saline extract of pitui-tary or a good adrenotropic extract. Neither gonadotropic or thyrotropic hormone extracts plus estrogen caused any mammary growth. 
Lyons, Simpson and Evans (1942) found that wh.ereas a lacto-genic extract plus thyroxin plus glucose in hypophysectomized ani-mals did not cause any lobule-alveolar growth, a lactogenic extract plus estrogen was slightly effective. They also secured excellent lobule-alveolar growth in hypophysectomized animals given estrogen (or F. S. H.) plus an extract containing adrenotropic, growth and lactogenic hormones. 
Reece and Leonard (1941, 1942) secured slight mammary growth in hypophysectomized-castrate rats with growth hormone extract alone, while growth hormone ·plus estrogen or testosterone propion-ate was more effective in causing such growth. It may be seen from this review of experiments that anterior pituitary extracts whic.h have stimulated mammary growth have been rich in lactogen, adrenotropin and growth hormone. Extracts rich in thyrotropin or gonadotropin have shown little or no mammary growth effects. 
The development of sensitive technics for assaying pituitary materials and extracts for their potency in mammogen, lactogen, thyrotropin and gonadotropin has made possible this quantitative study of the relation of the mammogenic lobule-alveolar growth factor to these other anterior pituitary hormones. The purpose of this section, then, is to present a comparison of the mammogenic lobule-alveolar growth factor content of a group of pituitary extracts with their lactogenic, thyrotropic and gonado-tropic hormone contents. The extracts varied widely in their con-
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tent of the different hormones. Such a comparison should reveal 
whether or not the mammogenic fraction is identical with or is 
primarily associated with any one of these other pituitary hormones. 
2. Procedure.-Fourteen anterior pituitary materials and ex-
tracts were assayed for their lactogenic and mammogenic lobule-
alveolar growth hormones. Three of these fourteen were also assayed 
for their content of the thyrotropic and gonadotropic hormones. One 
additional extract was assayed for its thyrotropic, gonadotropic 
and mammogenic hormone content. These extracts varied in 
nature from fresh anterior pituitary of cattle to a very highly purified 
lactogenic extract (30 I. U. per mg.), and also to an extract very high 
in thyrotropic and gonadotropic hormones. Lactogenic assays were 
made according to the method of McShan and Turner (1936). The 
thyrotropic and gonadotropic hormone assays were made using the 
Bergman-Turner chick methods (Bergman and Turner, 1939, and 
Bergman, Houchin and Turner, 1939). 
3. Experimental.-The data for the fifteen anterior pituitary ex-
tracts which were assayed for the mammogenic lobule-alveolar growth 
factor are presented in Table 13. Some of these extracts were 
very high in their content of lactogenic hormone, while one, Thyr. 
2a-40, was especially high in the thyrotropic and gonadotropic hor-
mones. It will be seen from the data that there was a very good 
correspondence between the dosage of extracts injected and the per 
cent positive mammary responses obtained. 
Fourteen of the fifteen extracts assayed for the lobule-alveolar 
growth factor were also assayed for lactogenic hormone (Table 14). 
As may be seen from the right hand column in this table, the Inter-
national Units of lactogen per mammogenic unit range from approxi-
mately two to 352, a differential of 176 times Thus these preparations 
vary widely in their relative content of mammogen and lactogen. 
The more potent lactogenic preparations required extreme amounts 
of extract on a lactogen basis, as compared to the less potent .extracts, 
to secure lobule~alveolar growth. Of course it is possible that in the 
more . crude. extracts of the pituitary, synergistic relations may exist 
between the various pituitary factors and the mammogenic factor so 
that much less of the active principle was required. However, it 
is not thought that this synergism could be so great as to explain the 
mammary growth obtained in these experiments on the basis of lac-
togen as the active mammogenic factor. It is more probable that the 
mammogenic and lactogenic factors are separate entities, and that 
even in the purest amorphous lactogenic extract assayed, impurities 
of a mammogenic factor are present. 
It is incumbent upon those who 'Claim that "pure" protein hormones 
can be prepared (Li, Lyons and Evans, 1940, 1941a, 1941b, and White, 
Bonsnes and Long, 1942) to show that the physical-chemical methods 
for determining protein purity, such as have been suggested by 
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TABLE 13. LOBULE-ALVEOLAR RESPONSES OF CASTRATE FEMALE MICE INJECTED WITH VARIOUS ANTERIOR PITUITARY PREPARATIONS UNDER ASSAY CONDITIONS 
Anteri2r Eitllitar:i · Pr!:l12arfili211 Estrone, Lobule-Alveolar Total Total Number B.1::;;12211:011:;; Name Dosage, Dosage, of Mice + 
-
Per Cent Mg. I. u. Positive 
Lot 14, fresh anterior 35.0 75 13 7 6 53.8 pituitary, pregnant cattle 50.0 75 15 13 2 86.7 · 100.0 75 14 14 0 100.0 150.0 75 12 12 0 100.0 
Lot 15, fresh anterior 35.0 75 13 6 7 46.1 pituitary, pregnant cattle 
Lot 13, fresh anterior 50.0 75 13 8 5 61.5 pituitary, stockyard run 100.0 75 13 13 0 100.0 
of cattle 
Lot 14, acetone-ether 15.0 75 13 6 7 46.1 dried anterior pituitary, 30.0 75 12 12 0 100.0 pregnant cattle 45.0 75 3 3 0 100.0 
Lot 15, acetone-ether 15.0 75 14 8 6 57.1 dried anterior pituitary, 17.5 75 13 9 4 69.2 pregnant cattle 
Lot 13, acetone-ether 20.0 75 13 8 5 61 .5 dried anterior pituitary, 40.0 75 6 6 0 100.0 
stockyard run of cattle 
Lot 13, initial extract 7.5 75 35 18 17 51.4 
of anterior pituitary, 10.0 75 21 12 9 57.1 
stockyard run of cattle 12.5 75 23 20 3 87.0 
17.5 75 34 33 1 97.1 
Cattle lactogenlc 3 9 5.0 75 3 0 3 0.0 
10.0 75 12 5 7 41.7 
12.5 75 22 20 2 90.9 
20.0 75 4 4 0 100.0 
40.0 75 4 4 0 100.0 
Schering 46-51-pr4 10.0 75 10 5 5 50.0 
15.0 75 10 8 2 80.0 
20.0 75 2 2 0 100.0 
CI341-70 10.0 75 12 4 8 33.3 
13.5 75 11 5 6 45.5 
Schering 48-hy-ex.4 7.5 75 11 6 5 54.5 
15.0 75 5 5 0 100.0 
20.0 75 6 6 0 100.0 
Lac. la-40 10.0 75 11 0 11 0.0 
12.5 75 5 1 4 20.0 
20.0 75 8 4 4 50.0 
25.0 75 4 3 1 75.0 
37.5 75 4 3 l 75.0 
.50.0 75 3 3 0 100.0 
L-1-41-60 15.0 75 12 6 6 50.0 
L-1-41-70 20.0 75 13 8 61.5 
Thyr. 2a-40 10.0 75 13 0 13 0.0 
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TABLE 14. COMPARATIVE MAMMOGENIC AND LACTOGENIC HORMONE 
ASSAYS ON A GROUP OF .ANTERIOR PITUITARY PREPARATIONS 
Mg. Extract I. U. of Lactogen I. U. of Lactogen 
Preparation Per Mammogenic Per Mg.-of Per Mammogenic 
Unit Extract Unit 
Lot 14, fresh anterior 35.0 0.06 2.1 
pituitary, pregnant cattle 
Lot 15, fresh anterior 
pituitary, pregnant cattle 35.0 0.06 2.1 
Lot 13, fresh anterior 44.0* 0.06 2:6 
pituitary, stockyard run 
of cattle 
Lot 14, acetone-ether 15.0 0.3 4.5 
dried anterior pituitary, 
pregnant cattle 
Lot 15, acetone-ether 
dried anterior pituitary, 15.0 0.3 4.5 
pregnant cattle 
Lot 13, acetone-ether 17.6* 0.3 5.1 
dried anterior pituitary, 
stockyard run of cattle 
Lot 13, initial extract 7.5 4.5 33.8 
of anterior pituitary, 
stockyard run of cattle 
Cattle lactogenic 3 9 10.0 4.0 40.0 
Schering 46-51-pr4 10.0 12.0 120.0 
CI3 41-70 13.5 12.0 162.0 
Schering 48-hy-ex.4 7.5 30.0 225 .0 
L-la-40 20.0 12.0 240.0 
L -1-41-60 15.0 18.0 270.0 
L-1-41-70 17.6* 20.0 352.0 
*Corrected to basis of 50 per cent positive responses from 61.5 per cent. 
Shedlovsky (1943), can detect extremely sµiall amounts of hormone 
contaminant that will give physiological responses with sensitive assay 
technics. If, for instance, extremely small amounts of lactogen were 
added to pure casein, would the physical-chemical methods for deter-
mining purity of proteins be able to detect such contamination in 
view of the extremely small amount of lactogen required to give 
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positive responses with the sensitive intradermal test (Lyons and Page, 1935)? 
The case seems more complete for the separateness of the mammo-genic factor from the thyrotropic and gonadotropic hormones. A 
thyrotropic-gonadotropic extract, Thyr. 2a-40 (Table 13) , which con-
tained ten chick units of thyrotropin per mg. and four chick units 
of gonadotropin per mg., failed to elicit any mammary growth when 
assayed at the ten-mg. level, a total of 100 c. u. of thyrotropin and 40 
c. u. of gonadotropin. These amounts of hormone great ly exceed the 
amount present in a mammogenic unit of any of the other three ex-
tracts assayed for gonadotropic and thyrotropic hormones. The com-parative content of mammogen, thyrotropin and gonadotropin of these four extracts are presented in Table 15. The chick units of thyro-
tropin per mammogen unit varied from 1.31 to at least 100, a differ-
ential of at least 80 times, while the chick units of gonadotropin varied from 0.095 to at least 40, a differential of at least 400 times. It is thus 
rather apparent that the mammogenic factor is not associated with 
either the thyrotropic or gonadotropic hormones. 
· Extracts were not available which were known to consist predomi-
nantly of adrenotropin or growth hormone, so it was not possible to 
make any comparison of mammogen with these two factors. 
TABLE 15. COMPARATIVE MAMMOGENIC, THYROTROPIC AND GONADOTROPIC HORMONE ASSAYS ON A GROUP OF ANTERIOR PITUITARY PREPARATIONS 
Mg. Extract IhUQil:QlliC* QQDi!MtQlliC * Preparation Per C.U. Per C.U. Per C.U. Per C.U. Per Mammogenic Mg. Mammogenic Mg. Mammogenlc Unit Extract Unit Extract Unit 
CI3-41-70 13.5 0.097 1.31 0.007 0.095 
Lot 13, acetone-
ether dried 
anterior pituitary, 17.6** 0.278 4.89 0.110 1.936 stockyard run of 
cattle 
Lot 13, initial 
extract of anterior 7.5 2.943 22.07 0. 776 5.720 pituitary, stock-
yard run of cattle 
Thyr. 2a-40 No response 10.000 At least 4.000 At least 
at 10 mg. 100 40 
*Chick Units 
**Corrected to basis of 50 per cent positive r~sponses from 61.5 per cent 
· 4. Discussion.-As the pituitary is subject to intensive study as 
to its physiological activities, new functions are being found. It is of prime interest to determine then if the newly-observed activity 
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of the pituitary is ascribable to some already identified hormone or 
whether it may be put in the class of new hormones. Until such time 
as the factor responsible for a certain activity has been chemically 
isolated and purified, our only tool in determining its possible identity 
with other hormones is the use of comparative assays on various 
types of extracts. 
The use of comparative assays on various types of pituitary ex-
tracts was used in this study to determine the possible identity of the 
mammogenic lobule-alveolar growth factor with other anterio.r pitui-
tary hormones. 
Although these results cannot be considered as conclusive, they 
do indicate that the lobule-alveolar growth factor is not identical 
with lactogen, thyrotropin or gonadotropin. 
D. Progesterone-like Activity of Some Steroid Compounds and of 
Diethylstilbestrol in Stimulating Mammary 
Lobule-Alveolar Growth. 
1. Review of Literature.-Following the purification, isolation 
and synthesis of progesterone, it was shown that this hormone stimu-
lated progestational proliferation of the endometrium, induced sexual 
receptivity in the guinea pig and also stimulated the growth of the 
mammary lobule-alveolar system. For a time it was thought that pro-
gesterone was specific for these functions, but now numerous other 
compounds are known to have these same properties, but to a lesser 
degree than progesterone. 
Both testosterone and methyl testosterone have been shown to have 
slight progesterone-like activity in stimulating progestational pro-
liferation of the endometrium (Klein and Parkes, 1937). Emmens 
and Parkes (1939) reported that a new synthetic hormone, preg-
neninolone (ethinyl testosterone or anhydro-hydroxy-progesterone), 
possesses about one-tenth the activity of injected progesterone in 
promoting progestational proliferation of the rabbit endometrium, 
and that it was equally potent by mouth or injection. Definite pro-
gestational proliferation was produced in the endometrium of post 
menopause women with pregneninolone administered orally after pre-
liminary priming with estradiol benzoate (Salmon, Walter and Geist, 
1939). An adrenal-cortical compound, desoxycorticosterone and its 
acetate, have been shown to promote progestational proliferation of 
the endometrium (Van Heuverswyn et al., 1939, and Leathern and 
Crafts, 1940). 
· 
Hertz, Meyer and Spielman (1937) have reported on the specificity 
of progesterone in inducing sexual receptivity in the ovariectomized 
guinea pig. However, Van Heuverswyn et al. (1939) found that 
desoxycorticosterone has one-sixth to one-tenth the activity of pro-
gesterone in inducing sexual receptivity. Tortsveit and Mellish (1941) 
similarly have reported that aqueous extracts of the adrenal cortex 
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containing the life-maintaining principle produced the copulatory re-flex in properly conditioned guinea pigs. 
There are a limited number of reports which indicate that sub-
stances other than progesterone may cause the development of the lobule-alveolar system. Mixner and Turner (1941b) reported in a preliminary paper that pregneninolone was about one-half as active 
as progesterone in stimulating alveolar growth. Speert (1940b) found that desoxycorticosterone acetate caused lobule growth in mature 
spayed monkeys whose glands had invoiuted following castration. Similarly Chamorro (1940) reported that the injection of desoxycorti-
costerone acetate plus estradiol benzoate caused lobule"alveolar growth in hypophysectomized male rats. Both substances were inactive alone. Dodds, Lawson and Noble (1938) secured: fulli mammary gland growth with diethylstilbestrol in the guinea pig. Lewis and Turner (1941a, 1941b, 1942b, 1942c) also secured limited proliferation of the lobule-alveolar system of mice, rats, guinea pigs, rabbits and goats 
with diethylstilbestrol. Selye, McEuen and Collip (1936), Nelson 
and Merckel (1937), Astwood et al. (1937), Noble (1939), Reece and Mixner '(1939), and Folley et al. (1939) reported on the ability of 
testosterone to stimulate the growth of the mammary lobule-alveolar zy~~-
. 
The following section reports the results of a study to determine the 
relative activity of progesterone, other steroids and diethylstilbestrol in stimulating mammary lobule-alveolar growth in the ovariectomized 
mouse. These relations as determined are taken to indicate the rela-tive ability of these materials to stimulate the increased production 
of the mammogenic lobule-alveolar growth factor by the pituitary of the assay animal. 
-
2. Experimental.-Progesterone, pregneninolone, desoxycortico-
sterone acetate, dehydroandrosterone, diethylstilbestrol, acetoxy-preg-
nenolone, methyl testosterone and testosterone were assayed for their ability to stimulate lobule-alveolar growth (Table 16 and Fig. 7) using the assay method already developed. Progesterone and preg-
neninolone assays (with and without estrone) were reported earlier in Part B of the Experimental Section. They are repeated here so that they may be compared directly with the other compounds. Progesterone was the most potent substance assayed for its 
ability to stimulate lobule growth, followed by pregneninolone which possessed one-half the potency of progesterone according to the assay data. 
Both desoxycorticosterone acetate and dehydroandrosterone pos-
sessed considerable potency also, having roughly one-third the activity 
of progesterone. 
Foi.; ng. of diethylstilbestrol were required for an assay response. This dose of material caused a slight weight decrease in the animals 
over the ten-day assay period. A six-mg. dose, however, severely de-
creased the body weights of the assay animals, and this was reflected 
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TABLE 16. LOBULE-ALVEOLAR RESPONSES OF CASTRATE FEMALE MICE 
TO SOME STEROID COMPOUNDS AND DIETHYLSTILBESTROL 
~QillJ:!QJ.!Il!l Estrone, Lobule-Alveolar 
Total Total Number ResMns es 
Name Dosage, Dosage, of Mice + Per Cent 
Mg. I. u. Positive 
Progesterone 0.025-0.25 133 16 0 16 0.0 
0.50 133 16 4 12 25.0 
o. 75 133 12 5 7 41.6 
1.00 133 10 6 4 60.0 
1.25 133 12 10 2 83 .3 
1.50 133 3 3 0 100.0 
Pregneninolone 1.0 133 12 1 11 8.3 
1.5 133 12 3 9 25.0 
2.0 133 12 7 5 58.3 
2.5 133 10 9 1 90.0 
5.0- 10.0 133 12 12 0 100.0 
Desoxycorticosterone 2.0 75 12 4 8 33 .3 
acetate 3.0 75 9 5 4 55.6 
4.0 75 12 8 4 66. 7 
5.0 75 7 6 1 85. 7 
Dehydroandrosterone 2.0 75 12 4 8 33.3 
3.0 75 12 5 7 41.7 
5.0 75 11 9 2 81.8 
Diethylstilbestrol 2.0 75 12 1 11 8 .3 
4.0 75 12 6 6 50.0 
6.0 75 12 4 8 33.3 
Progesterone 3.33 24 2 22 8.3 
4.67 24 5 19 20.8 
6.00 26 15 11 57. 7 
7.33 24 17 7 70.8 
Pregneninolone 2.5-5.0 10 0 10 0.0 
7.5 8 2 6 25.0 
10.0 12 5 7 41. 7 
12.5-20.0 16 16 0 100.0 
Acetoxy-pregnenolone 5.0 75 8 0 8 0.0 
10.0 75 12 4 8 33 .3 
Methyl testosterone 5.0 75 7 0 7 0.0 
10.0 75 12 2 10 16. 7 
Testosterone 2.0 75 4 0 4 0. 0 
4.0 75 4 0 4 0.0 
6.0 75 3 0 3 0. 0 
10.0 75 11 0 11 o.o 
Testosterone 5.0 75 8 0 8 o.o 
propionate 10.0 75 6 0 6 0.0 
0 .s 
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Fig. 7.-Comparison of progesterone and other progesterone-like compounds in their 
ability to stimulate the mammary lobule-alveolar systems of ovariectomized mice, plotted 
on arithlog paper. 
in the reduced response secured with the higher dosage. It appears 
that while diethylstilbestrol will stimulate lobule-alveolar growth in 
reasonably small amounts, it is very toxic at higher levels and there-
fore at dosages which should cause good alveolar growth the toxic 
properties predominate to the disadvantage of mammary gland growth. 
Selye (1941) reported that acetoxy-pregnenolone, an intermediary 
product in the Steiger-Reichstein synthesis of desoxycorticosterone 
acetate possessed corticoid activity only slightly less than desoxycorti-
costerone acetate. In this study ten mg. of acetoxy-pregnenolone with 
estrone caused four of twelve mice to respond with lobule-alveolar 
growth. This would make it approximately one-sixteenth as potent 
as progesterone or one-fifth as active as desoxycorticosterone acetate 
in stimulating lobule-alveolar growth. 
Ten mg. of methyl testosterone caused two of twelve mice to re-
spond with alveolar growth indicating that it is approximately one-
twenty-fifth as active as progesterone in this respect. 
Although it has been widely shown that testosterone stimulates 
lobule-alveolar growth in certain animals, these experiments indicate 
that testosterone plus estrone is ineffective in stimulating lobule-
alveolar growth in the mouse in dosages as high as ten mg. during a 
ten-day period. ' 
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3. Discussion.-The relative activity of progesterone, pregnen-
inolone, desoxycort icosterone acetate and methyl testosterone in pro-
moting mammary lobule-alveolar growth corresponds in a rough way 
to the relative activity of these substances in stimulating progestational 
proliferation of the endometrium as reported in the literature. It 
appears that the early idea on the specificity of progesterone must be 
revised as it is now apparent that numerous steroids have pro-
gesterone-like activity in varying degrees. 
It is interesting to note the failure to secure lobule-alveolar growth 
with testosterone or the propionate in the mouse reported in t hese 
experiments as contrasted to the numerous reports in the literature 
of positive results with other species. 
E. The Influence of Certain Adverse Conditions on the Growth of 
the Mammary Gland. 
1. Review of Literature.-1\fany studies have been reported in-
dicating that variations in such environmental factors as light, tem-
perature, and diet influence the secretion of the anterior pituitary 
hormones. However, in several instances it has been shown that these 
same factors do not adversely influence the ability of the end organs 
such as the thyroid and gonads to respond to their direct growth 
stimuli. Thus in the case of underfeeding, Breneman (1940) has 
shown that the testes are responsive to less gonadotropic hormone 
·than glands of animals on a normal ration, and similarly Stevens 
(1940) has shown that the thyroids are responsive to less thyrotropic 
hormone than normal-fed animals. 
This same problem enters into the question of whether it is neces-
sary to postulate a pituitary mammary growth factor because in most 
instances it is impossible to secure mammary growth with ovarian 
hormones in the absence of the pituitary. It is acknowledged that 
hypophysectomy constitutes an unfavorable factor which interferes 
with food intake and many other body processes, and thus it might be 
difficult to secure mammary growth in such animals with the ovarian 
hormones. 
Astwood, Geschickter and Rausch (1937) restricted the diet of 
normal rats and at the same time injected estrogen. No mammary 
growth could be secured in such animals. Normal rats on unrestricted 
diets responded with good mammary growth. They concluded that the 
ineffectiveness of ovarian hormones in hypophysectomized animals was 
insufficient evidence for the claim that mammary growth is mediated 
by the pituitary. 
Selye and Collip (1936) secured no mammary growth with estrogen 
in hypophysectomized rats whose gonads and adrenals were maintained 
i.n good condition with a pituitary extract. 
Nathanson, Shaw and Franseen (1939) similarly reported that 
estrogen did not cause mammary growth in hypophysectomized rats 
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even when a pituitary growth extract was also injected, maintaining 
normal body weight of the hypophysectomized animals similar to 
those of controls. ·They conclude that although nutrition is important, 
the sex hormones must act through the pituitary to cause mammary 
gland growth. 
Samuels, Reinecke and Petersen (1941) attacked this problem from 
a different angle. Hypophysectomized animals were force-fed, given 
thyroid, sodium chloride and adrenal cortical extract. The mammary 
glands of such animals in which normal body weight was maintained 
failed to respond to estrogen. They suggested that either changes in 
metabolism caused by the pituitary were necessary for mammary 
growth or estrogen acts through the anterior pituitary to cause mam-
mary growth. 
Trentin and Turner (1941) have further studied the effect of inani-
tion on responsiveness of the mammary gland to estrogen. If the food 
intake of male mice was decreased by fifty per cent, the requirement of 
estrogen for mammary growth was increased by sixteen times. It was 
significant, however, that mammary growth could be secured with 
high dosages of estrogen when the food intake was greatly reduced. 
Thus Astwood et al. (1937) probably could have secured mammary 
growth with higher dosages of estrogen in rats in which the food in-
take was limited or restricted. 
· 
In view of the above experiments it seemed of interest to deter-
mine the influence of an adverse factor (high environmental tempera-
ture) upon the responsiveness of the mammary lobule-alveolar system 
to progesterone and an anterior pituitary extract containing the mam-
mogenic lobule-alveolar growth factor. 
It might be predicted from the above discussion that (1) if pro-
gesterone acts indirectly on the mammary gland by means of the pi-
tuitary, the high temperature would adversely affect the ability of 
progesterone to stimulate mammary-lobule growth and that (2) if the 
pituitary factor acts directly on the mammary gland to cause alveolar 
growth, the high temperature would not adversely affect the ability 
of the pituitary extract to cause lobule-alveolar growth. 
2. Experimental.-Groups of assay mice were maintained in con-
stant temperature chambers regulated to 25 ° and 35° C. respectively. 
· A complete grain ration .was fed to all mice ad lib.itum. Some mice 
were injected with progesterone plus estrone while others were in-jected with an anterior pituitary extract plus estrone, groups of each 
being kept in the 25° and 35° chambers. At the 35 ° C. temperature 
approximately fifty per cent of the animals on both progesterone and 
the pituitary extract died during the ten-day assay period. Only 
the surviving animals are included in the data presented in Table 17. 
At the more normal temperature of 25° C., 1.25 mg. of progesterone 
and 75 I. U. of estrone stimulated lobule-alveolar growth in 51.7 per 
cent of the animals. This is considered a unit response. On the 
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TABLE 17. EFFECT OF HIGH ENVIRONMENTAL TEMPERATURE ON LOBULE-ALVEOLAR 
RESPONSES OF CASTRATE FEMALE MICE INJECTED WITH PROGESTERONE AND A 
PITUITARY EXTRACT 
Ini!:CtiQn Mil:t!ltiill::i Estrone, Lobule-Alveolar 
Total Total Environmental Number Responses 
Name Dosage, Dosage, Temperature, of Mice + Per Cent 
Mg. I.U. oc Positive 
Progesterone 1.25 75 25 29 15 14 51. 7 
1.25 75 35 15 1 14 6.7 
Anterior 12.5 75 25 15 13 2 86.7 
pituitary 12.5 75 35 8 7 1 87.5 
preparation 
17 .5 75 25 14 13 1 92. 9 
17 .5 75 35 8 8 0 100.0 
same level of hormone injection but at 35° C. the response dropped 
to 6.7 per cent. Thus the high temperature adversely affected the 
ability of the anterior pituitary gland to secrete the mammogenic 
lobule-alveolar growth factor in response to the stimulation of pro-
gesterone and estrone. This is in contrast to the results secured 
with the pituitary extract. Here the groups receiving 12.5 mg. and 
17.5 mg. of pituitary extract responded equally well in both the 25° 
and 35 ° C. temperature groups. It is apparent that the high tempera-
ture in no way inhibited the ability of the mammary glands, as end 
organs, to r,espond to their direct growth stimulus. 
3. Discussion.-Previous experiments indicated that undernutri-
tion in mice and rats constituted an adverse condition which prevented 
the mammary glands from responding in a normal manner to the 
injection of estrogen. Under-nutrition may affect the pituitary in such 
a way that it is no longer stimulated to the increased production of 
mammogen by normally optimal amounts of estrogen. 
Indeed, excess amounts of estrogen itself may constitute an ad-
verse factor. Gardner (1941a) found that large amounts of estrogen 
inhibited mammary growth. Similarly, a large amount of estrone 
inhibited the normal effect of progesterone in stimulating lobule-
alveolar growth (Table 8). It is not improbable that the pituitary 
agairi is the organ which is affected to the disadvantage of mammary 
growth. This is further borne out by the experiments of Lewis and 
Turner (1939) in which large amounts of estrone decreased the mam-
mogen content of pituitaries of rabbits as compared with pituitaries 
of rabbits injected with more optimal amounts of estrone. 
In the present experiments high environmental temperature was 
another of thes~ factors which prevented normal mammary gland 
stimulation by progesterone and estrone. This high temperature did 
not affect the normal mammogenic action of pituitary extract plus 
estrone. 
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It is suggested that the various experiments on undernutrition, high 
estrogen administration and high environmental temperature are harmonious with, and contribute to, the concept of the pituitary-mam-
mogen theory of mammary gland growth .. 
F. Influence of Thyroxine and Thyroidectomy upon Mammary 
Lobule-Alveolar Growth. 
1. Review of Literature.-Thyroid tissue, thyroxine and synthetic 
thyroprotein have been demonstrated repeatedly to have a stimulating 
effect upon lactation in dairy animals (Herman et al., 1938, Ralston 
et al., 1940, and Reineke and Turner, 1942). The effect of thyroxine 
on the growth of the mammary duct and lobule-alveolar systems is less 
clear. 
Dragstedt, Sudan and Phillips (1924) observed that the complete 
absence ·of the thyroid and the parathyroid in the dog did not pre-
vent growth of the mammary gland during pregnancy and secre-
tion of milk after delivery. 
Weichert and Boyd (1933, 1934) found that normal female rats fed desiccated thyroid became pseudopregnant while pregnant rats fed thyroid showed a precocious development of the mammary gland 
which was especially marked from the seventh to the ninth days of pregnancy. There was also an early appearance of secretion. 
No mammary growth was obtained in ovariectomized adult rats fed desiccated thyroid (Weichert, Boyd and Cohen, 1934) . 
. Cohen (1935) observed changes in the mammary glands of male 
ra"ts fed desiccated thyroid. Normal males had poorly defined lumina 
of alveoli while thyroid-fed males had well arranged lumina of the 
alveoli. 
Leonard and Reece (1941) reported that thyroidectomy in normal, young female rats, in spayed female rats and in estrogen-treated 
spayed rats caused a thickening of . the mammary ducts and an increase in the number of lateral and end buds as compared to 
appropriate controls. Thyroxine given to these animals prevented 
these changes. 
Smithcors and Leonard (1942) claimed that thyroidectomy in 
normal immature male rats inhibited mammary duct growth and 
stimulated lobule-alveolar growth. Thyroidectomy in castrated male 
rats gave similar results but to a lesser degree. Testosterone pro-pionate or estradiol dipropionate cau::;ed inhibition · of ·mammary duct growth but an exaggeration of the alveolar system in thyroid-
ectomized, castrated male rats. 
Mammary glands of intact male mice fed desiccated thyroid in 
their feed showed evidence of duct stimulation. Thyroid was in-
effective in castrate mice (Gardner, 1942). 
The development of an assay technic for substances which stim-
ulate mammary lobule-alveolar growth has made possible the study 
42 MISSOURI AGRICULTURAL EXPERIMENT STATION 
of factors which influence such growth. In this section experi-
ments on the influence of thyroxine and thyroidectomy on mammary 
lobule-alveolar growth stimulation by progesterone and estrone 
and by a pituitary extract are reported. 
2. Experimental.-Groups of assay animals were injected with 
constant amounts of progesterone and estrone over the standard 
ten-day assay period. Using these groups the effect of injecting 
varying amounts of thyroxine or of thyroidectomy on lobule growth 
was determined. The animals in group 1 (Table 18) serve as a 
control group for the next four groups of animals. In the controls, 
35 per cent positive lobule-alveolar responses were secured in twen-
ty animals. The same response was secured when 150 micrograms 
of thyroxine were giyen in addition to the progesterone and es-
trone (Group 2). However, when the thyroxine was increased 
to 1500 micrograms in group 3, the percentage of positive responses 
increased to 64.5 per cent, indicating that in some manner the thy-
roxine was increasing the efficiency of action of the progesterone 
and estrone. This increase was considered to be significant in 
comparison with the level of 35 per cent in control group 1. 
Group 4 which received 4500 micrograms gave only the control 
level of response. This was interpreted as indicating that there 
is an optium thyroxine level for the synergism observed. 
TABLE 18 - EFFECT OF THYROXINE AND THYROIDECTOMY ON LOBULE-ALVEOLAR 
RESPONSES OF CASTRATE FEMALE MICE INJECTED WITH PROGESTERONE AND A 
PITUITARY MATERIAL 
Ini!l~t!Qn Material Estrone, Thyroxine, Lobule-Alveolar 
Group Total Total Total Number B!:Sl2QDS~S 
Number Name Dosage Dosage, Dosage, of Mice + Per Cent 
Micrograms Microg:rams Positive 
Micrograms 
1 Progesterone 750 7.5 20 7 13 35.0 
2 750 7.5 150 20 7 13 35.0 
3 750 7.5 1500 31 20 11 64.5 
4 750 7.5 4500 18 6 12 33.3 
5 750 7.5 * 12 1 11 8.3 
6· 1000 13.3 10 6 4 60.0 
7 1000 13.3 1500 9 9 0 100.0 
Milligrams 
8 Anterior 7.5 7.5 18 9 9 50.0 
9 pituitary 7.5 7.5 1500 18 1 17 5.6 
10 extract 7.5 7.5 ** 14 2 12 14.3 
11, 7.5 1500 10 0 10 0.0 
* Thyroidectomized fifty days before start of injections 
** Thyroidectomized five days before start of injections 
To determine the activity of progesterone and estrone in the ab-
sence of the thyroids, a group of animals (Group 5) were thyroidec-
tomized 50 days before progesterone and estrone injections wne 
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begun and were ovariectomized only shortly before the beginning 
of injections. Here only one animal of twelve (8.3 per cent) re-
sponded with lobule-alveolar growth which further indicates that 
thyroxine is needed to secure optimal mammary growth. 
In groups 6 and 7, the mice received 1000 micrograms of proges-
terone and 13.3 micrograms of estrone while group 7 received in 
addition 1500 micrograms of thyroxine. Thyroxine increased the 
per cent positive responses from 60 to 100, further evidence in con-
firmation. of the previous observations. 
As 64.5 pei· cent positive responses were obtained from 750 mic-
rograms of progesterone plus 1500 micrograms of thyroxine (Group 
3) while 1000 micrograms of progesterone plus estrone gave 60 per 
cent positive responses (Group 6), it would appear that the efficiency 
of the progesterone was increased about 33.3 per cent by the action 
of the thyroxine. 
In groups 8, 9 and 10 a pituitary mammogenic extract was sub-
stituted for the progesterone. Group 8 served as a control for group 
9 which received in addition 1500 micrograms of thyroxine and for 
group 10 in which the animals were thyroidectomized five days 
prior to the beginning of injections. The thyroxine and thyroidec-
tomy inhibited mammary growth in both cases as the per cent 
positive responses dropped from 50 to 5.6 and 14.3 per cent respec-
tively. 
Group 11 received 1500 micrograms of thyroxine and 7.5 micro-
grams of estrone as a check on the possible mammary growth 
activity of the thyroxine under assay conditions. No lobule-alveo-
lar stimulation resulted. 
3. Discussion.-The enhancing effect of thyroxine on ma:rp.mary 
growth when stimulated by progesterone and estrone may be ex-
plained in several ways.· As thyroxine plays a role in somatic 
growth both in thyroidectomized (Reineke .and Turner, 1941) and 
normal animals (Koger, Hurst and Turner, 1942), it seems reason-
able to expect that thyroxine would also augment the growth of 
specialized tissues when they are subjected to the action of hormones 
which normally stimulate their growth as for instance, mammary 
growth stimulation by progesterone and estrone. Koger, Hurst and 
Turner (1942) observed that thyroxine in suitable dosage increased 
the growth rate of normal,. young, female mice about 25 per cent 
over that of non-injected controls. Carcass analysis indicated a 
· greater retention of nitrogen and water but a lesser percentage of 
fat than in controls. Thus the enhancing effect of thyroxine on 
mammary lobule-alveolar growth when stimulated by progesterone 
and estrone may be simply that of superimposing the general pro-
tein-growth stimulation of thyroxine upon the more specific mam-
mary lobule-alveolar growth stimulation of progesterone and estrone. 
Mammary growth being primarily protein in nature, a greater effect 
might be expected to result. 
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Another possibility is that thyroxine, through its effect in ele-
vating general body metabolism, accelerates the rate of cellular 
reactions and thus, although a certain optimal level of progesterone 
and estrone are necessary to direct the mechanism of mammary 
growth, the reaction as a whole is accelerated by thyroxine. 
The inhibiting effect of thyroxine on mammary gr owth with pitu-
itary extract (Group 9) was probably due to excessive thyroxine 
stimulation due to the combined effects of the injected thyroxine 
and the endogenous thyroxine stimulated by the thyrotropic hor-
mone in the pituitary extract injected. 
The thyroidectomized animals (Groups 5 and 10) injected with 
either progesterone or pituitary extract gave markedly inferior 
responses as compared with their appropriate controls, indicating 
in a negative way the need for thyroxine for optimal mammary 
growth. 
G. Mammary Lobule-Alveolar Growth in Goats. 
1. Review of Literature.-Both natural and synthetic estrogens 
and progesterone have been widely used in the stimulation of roam- · 
mary gland growth in the smaller experimental animals. It has been 
found generally that the estrogens stimulate primarily mammary 
duct growth and at times a limited amount of lobule-alveolar growth, 
while a combination of estrogen and progesterone stimulates com-
plete mammary gland development. 
Relatively few experiments on mammary growth using dairy ani-
mals have been reported, primarily because of the large size and cost 
of the animals and the relatively greater amounts of hormone re-
quired. Experiments on hormonal stimulation of lactation in dairy 
animals are more numerous. In some of these lactation experiments 
attempts have been made to judge the nature and degree of mammary 
growth on the basis of the amount of milk secreted and by palpation 
of the udder, histological techniques not being used. As considerable 
milk secretion can occur from a well extended duct system, the judg-
ment of mammary growth on this basis is liable to considerable error. 
De Fremery (1936, 1938) administered estradiol benzoate both 
subcutaneously and percutaneously on the udder to virgin female goats. 
He claimed that a growth of the udder to a size comparable with that 
observed during pregnancy was obtained. He concluded that · estrogen 
alone is sufficient for complete mammary growth in the goat, proges-
terone being unnecessary. These mammary glands were not examined 
histologically, size and milk secretion only being used as an indication· 
of udder growth. 
Lewis and Turner (194la, 1942c) reported that the administration 
of diethylstilbestrol to virgin or parous female goats caused limited 
growth of the mammary lobule-alveolar system. While in some cases 
treatment was carried out over extended periods of time, in no case 
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did the glands . appear comparable to the glands of normal, parturient · lactating animals. 
Folley et al. (194la) reported that they secured very limited duct 
and alveolar growth in two castrate male goats with stilbestrol treat-
ment. 
Walker and Stanley (1941) obtained fair lactation in two Jersey heifers following the injection of diethylstilbestrol dipropionate over a nine month period. In one of the heifers testosterone propionate supplemented the stilbestrol. They concluded that progesterone was 
not necessary for complete mammary development in cattle. Since histological examinations of the glands were not reported, the validity of the last statement may be questioned on the basis of insufficient 
evidence. 
As there seems to be some question regarding the necessity of both 
estrogen and progesterone in stimulating complete mammary lobule-
alveolar growth in the female goat, the experiments in the follow-ing section were designed to help clarify this subject. 2. Experimental.-The goats used in these experiments were nor-mal, virgin females ranging in age from one to two years and weigh-ing from 47 to 87 pounds. 
Both the diethylstilbestrol and the progesterone were dissolved in olive oil for injection purposes. When both of these compounds were injected into an animal, they were dissolved together in the same oil. All injections were made subcutaneously, once daily. The mammectomies performed were done under local anesthesia (two per cent apothesine). The liberal use of sulfanilamide in these 
operations prevented any serious infections. 
Mammary glands were prepared both for micro and macro inspec-tion. The ordinary paraffin microtome sections were cut at about twenty micra and stained with hematoxylin and eosin. Other mam-mary gland tissues were dissected out as thin sections containing in-dividual branches of the mammary tree. These sections were stained with hematoxylin and mounted in clarite. By examining microtome-
cut sections under a lOOx microscope and the dissected sections under a 20x dissecting scope, a very good picture of the state of mammary development was secured. Although it was felt that the dissected sections were superior to the microtome sections in judging mammary development, the dissected sections did not photograph well. In the experiments to be reported, mammary glands of goats in-jected with diethylstilbestrol were compared with other glands from goats injected with progesterone plus diethylstilbestrol. A constant 
ratio of one mg. of progesterone to five micrograms of diethylstilbestrol was maintained in all injections involving both compounds. Goat 518 served as a control in these experiments. The mammary glands of this animal showed only a complex branching of the duct system (Figs. 8 and 9) such as was reported by Turner and Gomez (1936). 
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Fig. 8.-A microtome section from a mammary glan d of goat 440 which received five mg. 
of proge'sterone and twenty-five micrograms of diethylstilbestrol daily for twenty-five days. 
similar to control goat 518 (58x). 
Fig. 9.-Dissection from a mammary gland of normal virgin female goat 518 (13x) . 
Figs. 10 and 11.-Microtome section (58x) and dissection (13x). respectively, from a 
mammary glarid of goat 443 w hich received twenty mg. of progesterone and 100 micrograms 
of d iet h ylstilbestrol daily for sixty da ys. A considerable development of the lobule-alveolar 
system has taken Place. 
Goat 440 received daily five mgs. of progesterone and twenty-five 
micrograms of diethylstilbestrol. Mammary glands were taken after 
twenty-five and sixty days of injection. No development was seen 
in either gland above that of the control (Figs . . 8 and 9). 
Two other goats (833 and 881) were injected daily with ten mg. of 
progesterone and fifty micrograms of diethylstilbestrol. Goat 833 
died after twenty-five days. Examinations of the glands showed no 
development . above that of the control. Goat 881 was injected for 
sixty days at which time there was still no observable development 
of the lobule-alveolar system. 
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Goats 443 and 198 received daily doses of twenty mg. of progesterone 
plus 100 micrograms of diethylstilbestrol and thirty mg. of proges-
terone plus 150 micrograms of diethylstilbestrol, respectively, for sixty 
days. At this time the mammary glands of these animals (surgically 
removed) showed a great development of the lobule-alveolar system, 
characterized by lobules of rather tightly packed, unhypertrophied 
alveoli. (Figs. 10 and 11). Fig. 11 presents very well the type of 
growth present at sixty days. It corresponds to the glands of goats 
observed at mid-pregnancy (Turner and Gomez, 1936) . It was 
thought to be of interest to determine the appearance of such a gland 
if it was stimulated to secretion. Therefore, these goats ( 443 and 
198) received after sixty days of progesterone-diethylstilbestrol treat-
ment a further treatment for twelve days of 0.25 mg. per day of 
diethylstilbestrol alone. At the end of this time · the goats were . 
killed and the mammary glands taken and examined. This additional 
diethylstilbestrol treatment caused the initiation of secretion and a 
consequent hypertrophy of the alveoli (Figs. 12 and 13) . This action 
was very marked, and caused an appearance of the gland similar to 
that seen at parturition (Turner and Gomez, 1936) . It might be added 
that the alveoli were entirely normal in appearance as seen under 
high-power magnification. These experiments involving progesterone 
and diethylstilbestrol simulate the normal growth of the mammary 
gland as seen during pregnancy and the initiation of lactation as ob-
served at parturition. 
Figs. 12 and 13.-Microtome section (58x) and dissection (13x), respect ively, from a 
mammary g land of goat 443 w hich after t he treat ment described in Figs. 10 and 11 received 
an additional t welve days injection of diethylstilbest rol at the rate of 0.25 mg. per day. Lactation was initiated, accompanied by alveolar hypertrophy. 
Two other goats, 188 and 438, received 0.25 and 0.10 mg. of 
diethylstilbestrol daily for sixty days, at which time mammary glands 
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Figs. 14 and 15.-Microtome section (58x) and dissection (13x), respectively, from a 
mammary gland of goat 188 which received 0.25 mg. of diethylstilbestrol daily, for sixty days. 
Very slight if any lobule-alveolar growth was stimulated, although a gre'at hypertrophy due 
to secretion was evident. 
Figs. 16 and 17.-Microtome section (58x) and dissection (13x), respectively, from a 
mammary gland of goat 569 which received diethylstilbestrol treatment at the rate of 0.25 
mg. daily for 138 days. Very slight stimulation of the mammary lobule-alveolar system is 
evident. 
were removed for examination. The gland of goat 188 (Figs. 14 and 
15) was characterized by a very great hypertrophy and swelling of 
the duct system with secretion. These ducts were greatly dilated, 
small milk cisterns being present in all parts of the gland. There 
was a very slight development of scattered groups of what appeared to 
be very large alveoli, not at all similar to that seen in normal lactation. 
Goat 438 presented a somewhat different picture. The great hyper-
trophy of the gland as seen in goat 188 was not evident in this goat_ 
Rather a slight development of the gland in the direction of lobule 
growth had taken place. This early lobule-alveolar growth was not at 
all comparable to that secured in goats 443 and 198 with progesterone 
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and diethystilbestrol in sixty days. Thus of these two goats receiv-
ing different amounts of diethylstilbestrol, the one receiving the lesser 
amount showed the greater degree of lobule-alveolar growth while the 
one receiving the greater amount showed by far the most secretion. 
Another study was made of the mammary glands of a group of goats 
on a diethylstilbestrol lactation experiment. Goats 258, 351, 176, 355 
and 569 were started on diethylstilbestrol injections at the rate of 
0.25 mg. per day. On the 90th day of injection milking was started 
and the injections were continued for thirty additional days, or a 
total of 120 days. At this time injections were discontinued for a 
31-day period and then started again and continued for the balance . 
of the experiment. After the experiment had been in progress 169 
days (138 days of which the animals were injected and 79 days of 
which they had been milked), the highest producing goat (258) had 
produced a maximum amount of milk per day of 690 ml. while the low-
est producing goat (569) had produced a maximum of 56 ml. per day. 
On the 169th day of the experiment mammectomies were performed . 
on goats 258 and 569. The low producing goat (569) showed a con-
siderable hypertrophy of the duct system with secret ion (Figs. 16 
and 17) but there was a conspicuous lack of any degree of development 
of the lobule-alveolar system. This is in contrast to the condition seen 
in the high producing goat (258). Here there was an extensive de-
velopment of the lobule-alveolar system which was greatly hyper-
trophied by secretion (Figs. 18 and 19). The alveoli of this gland 
were distinctly abnormal in respect both to size and structure. They 
were larger than alveoli of normal lactating goats and there was his-
tological evidence that they were still undergoing further division in 
the process of forming new and smaller alveoli. Furthermore the 
formed alveoli did not seem to be normal in that papillae of a cellular 
Figs. 18 and 19.-Microtome section (58x) and dissection (13x), respectively, from a 
mammary gland of goat 258 which had the same' treatment as goat 569 in F igs. 16 a nd 17. 
A rather extensive development of the lobule-alveolar system is seen, with evidence of great 
se'cretory activity~ 
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nature could be seen protruding into the lumina of the alveoli, indi-
cating that the alveoli were over one cell thick at many places. 
Mammary glands of the three remaining goats on the lactation ex-
periment, 351, 176 and 355, which were intermediate in milk produc-
tion between goats 268 and 569, were also removed seven days after 
the first group. These glands were very similar in appearance to 
those of the best producing goat, 258, (Figs. 18 and 19) , although 
rather less developed on the whole. 
3. Discussion.-De Fremery (1938) has been quoted by various 
reviewers (Folley et al., 194la, and Pet erson, 1942) as authority for 
the statement that estrogen will cause complete development of the 
mammary glands of goats, progesterone being unnecessary. De Frem-
ery, however, merely demonstrated that goats given a preliminary 
treatment of estradiol benzoate could be stimulated to good lactation 
by lactogen. No histological examination of the mammary gland tissue 
was reported as being made. It is well known that a mammary gland 
with a well developed duct system can be stimulated to copious lac-
tation with lactogen. 
In these experiments it was found that an adequate amount of pro-
gesterone together with a small amount of diethylstilbestrol was able 
to stimulate mammary lobule-alveolar growth in virgin female goats 
comparable to that seen at midpregnancy (Figs. 10 and 11). By 
further treating these glands with diethylstilbestrol alone for a short 
period, lactation was initiated accompanied by a great hyper trophy of 
the alveoli with secretion such as is seen at the time of normal par-
turition in goats (Figs. 12 and 13). 
The response of virgin female goats to diethylstilbestrol both in re-
gard to mammary growth and the degree of lactation stimulated was 
extremely variable. In some cases very slight if any stimulation of the 
lobule-alveolar system could be detected (goats 188 and 569). In 
other cases _a considerable development of the lobule-alveolar system 
was secured (goats 258, 351, 176 and 355). However, t he alveolar 
development secured in these cases was not histologically typical of 
that of normal lactating glands. The alveoli were much larger and 
less dense than normal lactating alveoli. The cells lining the alveoli 
were often more than one cell deep and atypical papillae-like struc-
tures were seen protruding into the lumina of the alveoli. 
These experiments are taken to indicate that although diethylstil-
bestrol may stimulate variable degrees of alveolar development, this 
development is not typical of that seen during normal pregnancy and 
lactation. Further, these experiments indicate that in all probability 
the growth of the mammary lobule-alveolar system occurring during 
pregnancy is accomplished by the joint action of progesterone and 
estrogen; and that contrary to previous reports, the goat should not 
be included in the list of animals in which progesterone is unnecessary 
to secure the complete and full development of the mammary gland 
such as occurs during normal pregnancy. 
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This discussion should not be taken to infer that diethylstilbestrol 
may not be a suitable agent for the stimulation of milk production in 
non-breeding dairy animals. It has been shown by Folley et al. (1940, 1941b) Walker and Stanley (1941), Lewis and Turner (1942d) and Reece (1943) that diethylstilbestrol will stimulate varying amounts 
of milk in dairy animals. Reece (1943) has been most successful to date in securing normal milk production in the cow. A 33 month old Jersey heifer which failed to conceive was injected over a thirteen 
week period with diethylstilbestrol dipropionate. Milking was then 
started and later a peak production of 33.7 pounds of milk testing 5.09 per cent fat was secured; 
The mechanism by which stilbestrol initiates lactation has been 
rather well established. In addition to stimulating the growth of the 
mammary gland, stilbestrol stimulates the pituitary to secrete a great-ly increased amount of the lactogenic hormone, thus causing the initiation of lactation (Reece and Turner, 1937, Lewis and Turner, 1941b, and Meites and Turner, 1942). 
DISCUSSION 
As these investigations have included a rather wide field of study, it is necessary to relate them to the overall picture of mammary gland growth. As a background for this discussion, a general con-
cept of the important endocrine factors controlling mammary gland growth in the female is schematically presented in Fig. 20. 
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Pig. 20.-Pituitary-ovary-mammary gland interrelationship in mammary growth. 
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Of the various endocrine glands, only the pituitary and gonads 
have been shown to be of prime importance in mammary growth. 
Although a compound, desoxycorticosterone, found in the adrenal 
cortex, has been shown to stimulate mammary duct (Van Heuver-
swyn, Folley and Gardner, 1939) and lobule-alveolar growth (Section 
D), it is not known that the adrenals play any direct part in mam-
mary gland growth. To definitely establish this point, it would be 
necessary to inject adrenalectomized animals maintained with salt 
therapy with ovarian hormones or pituitary mammogenic extracts. 
Positive results would indicate that the adrenals are not necessary 
for mammary growth. 
That the thyroids and parathyroids are not necessary for mam-
mary growth was demonstrated by Dragstedt et al. (1924) who 
found that completely thyro-parathyroidectomized dogs .had a nor-
mal hyperplas~a of the mammary glands during pregnancy. Of 
'Course it is known that experimentally induced hyperthyroidism 
in the normal female will induce pseudopregnancy and will cause 
a precocious development of the mammary glands of pregnant 
rats (Weichert and Boyd, 1933, 1934) . There have been other re-
ports indicating that the thyroids have an indirect role in mammary 
growth. In the experiments reported in Section F of this paper, 
the thyroids indirectly affected lobule-alveolar growth. 
The growth of the mammary gland up to the time of approaching 
sexua\ maturity closely follows body growth, indicating that in all 
probability the mammary gland is largely independent of hormonal 
control through this period. 
However, with the approach of sexual maturity in the female, 
the anterior pituitary gland begins the increased secretion of a gonado-
tropic hormone, known as the follicle stimulating hormone, which 
causes the growth of the ovaries, the maturation of the Graafian fol-
licles and the secretion of estrogen by these follicles. Estrogen has 
several functions: (1) it stimulates the pituitary to secrete an in-
creased amount of a mammogenic duct growth factor which directly 
stimulates mammary duct growth; (2) it acts directly upon the mam-
mary gland stromal tissue, increasing its vascularity and also in-
creasing the permeability of the capillaries so that more pituitary 
mammogen and nutrients reach the region of the growing gland 
(Section B) ; and (3) estrogen suppresses the production of the follicle 
stimulating hormone of the anterior pituitary and stimulates the 
increased secretion by the pituitary of the luteinizing hormone which 
induces ovulation and the formation of functional corpora lutea. It has 
been suggested that the corpora lutea are maintained during . preg-
nancy or pseudopregnancy by a third gonadotropic hormone, luteotro-
phin, which has been associated with lactogen by some investigators. 
A priori considerations would indicate that luteotrophin and lactogen 
are not the same hormone as (1) the level of lactogen secretion by the 
pituitary is low during pregnancy (Reece and Turner, 1937, and Holst 
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and Turner, 1939), not being significantly higher than in non-pregnant 
animals, and (2) in certain animals, the cow for instance, estrous cy-
cles are initiated after pregnancy at the height of lactat ion when the 
secretion of lactogenic hormone is at its highest level. 
The cyclic nature of duct growth, then, is due to the increased 
estrogen secretion of the ovary during the estrous phase of the cycle, 
acting both on the pituitary and on the mammary gland stromal 
tissue. 
Evidence has already been presented indicating that estrogen in-jections increased the pituitary content of a mammogenic factor. Con-
clusive evidence is not at hand at the present time which will show 
whether or not this mammogenic duct growth factor is a new hormone, 
separate from the other recognized hormone~. However, Gardner and White (1942) are of the opinion that this factor is lactogen. 
Progesterone is produced by 'the corpus luteum which persists after 
conception. It is suggested that progesterone stimulates the anterior pituitary to an increased secretion of a mammogenic lobule-alveolar growth factor which directly stimulates mammary lobule-alveolar growth. The estrogen present continues to influence favorably the 
vascularity and permeability of the capillaries in the mammary gland 
stroma, and thus not only synergistically influences the activity of the lobule-alveolar growth factor, but directly stimulates the growth of 
the teat and the mammary gland stromal tissue. 
There is no direct evidence at the present time that progesterone does cause the increased secretion of a pituitary mammogenic lobule-
alveolar growth factor, other than the facts that (1) progesterone 
will stimulate lobule-alveolar growth in normal animals, (2) proges-
terone is ihe:ffective in stimulating lobule-alveolar growth in hypophy-
sectomized animals, and (3) that pituitary materials do contain a lobule-alveolar growth factor. Data reported in this paper indicate 
that the lobule-alveolar growth factor is not identical with lactogen, gonadotropin or thyrotropin. Other workers, however, have associated lobule-alveolar growth activity with lactogen, adrenotropin and growth hormone. At the present time it still seems reasonable to post ulate 
that there is a specific mammogenic lobule-alveolar growth factor which is separate from the other known anterior pituitary hormones. 
Throughout the course o! these investigations there has been no 
reason to question the fundamental thesis that the sex hormones act 
through the pituitary to promote mammary gland growth in the normal 
animal both during puberty and pregnancy. However, several recent 
reports on this subject should be considered in the light of the dis-
cussion. Gardner (1940) secured slight mammary growth in hypo-physectomized male mice by the injection of desoxycorticosterone 
acetate, progesterone or estradiol dipropionate. Somewhat more growth was secured with either desoxycorticosterone acetate or pro-gesterone plus estradiol dipropionate. Gardner and White (1942) 
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secured additional confirmation of these observations. These results 
have been confirmed in part by Trentin and Turner (1942). 
Recently, Leonard (1943) reported that estradiol dipropionate stim-
ulated mammary gland duct end buds in hypophysectomized immature 
male or female rats if (1) they weighed less than 70 gms. at operation, 
(2) injections were begun immediately after operation, and (3) 
glands were examined after ten to twelve days of treatment. He 
suggested that mammary glands retain for a certain period of post-
natal life, potentialities for growth which can be stimulated by estro-
gen, but after this critical period this potentiality is lost and the cells 
are no longer affected by estrogen. 
It would seem from these reports that the mammary gland in com-
mon with several pituitary "target glands" retains for a limited period 
of time a ·measure of autonomous activity apart from the pituitary 
stimulation and control. This activity may be stimulated to a very 
limited extent by certain of the sex and adrenal hormones. An analo-
gous situation exists between the adrenal and the pituitary (Miller and 
Riddle; 1942). 
Although our knowledge of the exact mechanisms controlling mam-
mary gland growth is incomplete at the present time, it is felt that 
the theory of direct pituitary control of mammary gland growth as 
discussed in this paper is in general harmony with the existing data 
in this complex field of investigation. 
SUMMARY 
1. Mammary lobule-alveolar growth responses were secured in cas-
trate virgin female mice with anterior pituitary materials injected 
over periods of time ranging from four to ten days. These responses 
were not very predictable or repeatable on reassay. 
2. The simultaneous injection of pituitary preparations and a small 
amount of estrone greatly reduced the amount of pituitary required 
to secure alveolar responses and the dosages of pituitary preparations 
injected were proportional to the per cent positive lobule-alveolar re-
sponses secured in groups of assay mice. 
3. In the development of an assay method for the mammogenic 
lobule-alveolar growth factor, a ten-day assay period was found to be 
optimal. 
4. The length of time elapsing between ovariectomy of the assay 
mice and the beginning of injection affects the mammary response 
secured, the shorter the time, the greater the mammary response. 
5. An assay for the mammogenic lobule-alveolar growth factor was 
formulated. A mouse unit of this factor w.as defined as the amount of 
material required per mouse injected over a ten-day period to obtain 
minimal lobule-alveolar growth in 50 -+- 10 per cent of ten or more 
castrate nulliparous female mice when a total of 75 I. U. of estrone is 
simultaneously injected. Injection of the assay animals should start 
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immediately after ovariectomy unless they are first primed with es-
trogen for several days preliminary to the start of injections. 
6. Estrone in amounts of 40 I. U. to 133 I. U. were found to 
synergize best with one mg. of progesterone in stimulating mammary 
lobule-alveolar growth. Greater or smaller amounts of estrone did not 
give optimum synergism with progesterone. 
7. Progesterone or pregneninolone alone caused lobule-alveolar 
growth. However, five or six times as much was required as if estrogen 
was also injected. 
8. Although 2400 I. U. of estrone was able to completely inhibit 
the activity of a mouse unit of progesterone (one mg.), it was unable 
to inhibit the activity of a mouse unit of a pituitary preparation. 
9. As a result of a series of experiments with progesterone, preg-
neninolone, pituitary extracts and estrogen, it was suggested that 
estrogen enhances the activity of progesterone and pituitary materials 
in stimulating mammary lobule-alveolar growth by acting directly on 
the stromal tissue surrounding the mammary gland producing an 
increased hyperemia and vascularity associated with an increased per-
meability of the vascular system. This condition would allow a cir-
culating pituitary mammogen to be maximally effective in causing 
mammary gland growth. 
10. Both estradiol benzoate and diethylstilbestrol were able to sub-
stitute for estrone in conjunction with progesterone in enhancing 
mammary lobule-alveolar growth. 
11. Assays of various types of pituitary extracts showed that the 
mammogenic lobule-alveola,r growth factor is protein in nature. 
These assays also indicate that this factor is not identical with lacto-
gen, thyrotropin or gonadotropin. 
12. Progesterone, pregneninolone, desoxycorticosterone, dehydro-
androsterone, diethylstilbestrol, acetoxy-pregnenolone, and methyl tes-
tosterone ranked in the above order in their ability to stimulate 
mammary lobule-alveolar growth. 
13. 'High environmental temperature inhibited the ability of pro-
gesterone and estrone to stimulate mammary lobule-alveolar growth. 
This same high temperature was unable to inhibit the ability of a 
pituitary preparation to stimulate lobule-alveolar growth. 
14. Thyroxine in suitable amounts increased by about 33 per cent 
the efficiency of progesterone in stimulating lobule-alveolar growth. 
15. Thyroidectomy greatly decreased the efficiency of both pro-
gesterone and pit.uitary preparations in stimulating mammary lobule-
alveolar growth. 
16. Virgin female goats injected daily with twenty or thirty mg. 
of progesterone plus 100 or 150 micrograms of diethylstilbestrol, re-
spectively, for sixty days were stimulated to develop mammary glands 
similar to that seen in midpregnancy. Twelve days additional treat-
ment with 0.25 mg. daily of diethylstilbestrol caused an initiation of 
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secretion in these mammary glands similar to . that seen at the time 
of parturation. 
17. The response of virgin female goats to diethylstilbestrol in · 
regard to mammary lobule-alveolar growth was extremely variable. In some cases very slight stimulation of the lobule-alveolar system was 
effected while in others a considerable development was secured. 18. Lobule-alveolar growth secured with diethylstilbestrol injections in goats was not histological!y typical of that seen in normal lactating glands. The alveoli were much larger and less dense than normal lactating alveoli. Abnormal papillae-like structures were seen pro-
truding into the lumina of the alveoli. 
19. · The over-all picture of mammary gland development as affected by the various endocrine glands was discussed. 
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